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1
I N T R O D U C T I O N
Vaccines are among the most effective means for improving population
health.1–4 Smallpox, for example, which accounted for up to 500 million
deaths in the twentieth century, has been eradicated thanks to a global
vaccination programme.5 The polio eradication initiative reduced the
number of worldwide reported polio cases from 400,000 in 1988 to 22 in
2017.6 And the number of measle cases worldwide decreased between
2000 and 2015 by 75% due to vaccinations, averting an estimated 20.3
million deaths.7,8
Besides its beneficial effects, a vaccination carries the risk of causing
adverse events, as do other medical interventions. But because vaccines
are administered to healthy adults and children, the weight of the
benefits and risks (B/R) of a vaccine requires special consideration.9
Prior to licensure, the vaccine B/R profile is assessed during preclinical
and clinical development.10,11 The B/R profile after marketing, however,
is not entirely predictable from the preclinical and clinical assessment,
where only selective populations are included, and follow-up and size
of the investigated populations are limited. Therefore, the B/R profile of
a vaccine may change after licensure, for example due to the emergence
of rare and long-term side effects,12 or due to differing effectiveness
or risks in populations that were not covered by prelicensure clinical
trials (e.g., pregnant women or children). Passive surveillance systems
have been established to detect possible safety signals for medicines
and vaccines after marketing based on individual case reports (e.g.,
EudraVigilance in Europe and VAERS in the US).13,14
A potential change in the B/R profile of a vaccine necessitates the
reassessment of the profile based on available evidence regarding the
coverage, benefits and risks of the vaccine and based on the empirical
verification of cumulative life-cycle evidence in observational studies.
Undetected changes in the B/R profile – but also the very success of a
vaccination campaign by lowering the risk perception of the vaccine-
preventable disease in the public – can give rise to public concerns
towards vaccines, lowering the vaccine acceptance or even jeopardiz-
ing a vaccination programme.15 Safety concerns about vaccines and
changes in public sentiment have to be recognized early and acted on
by communicating established knowledge to maintain public trust. In
this context of post-licensure management of vaccines, the prompt and
accurate extraction of vaccine-related information is fundamental with
respect to three aims, which are addressed in this thesis: Listening to
1
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vaccine safety issues and changes of sentiment in the public, access-
ing established evidence about a vaccine, and empirically verifying
hypotheses about vaccine B/R in observational studies.
Vaccine-related information that is pertinent to these aims is available
in various resources. Potential safety concerns and public sentiment
are expressed in user-generated internet content (UGC) such as social
media. Established knowledge about vaccines is recorded in scientific
literature. And the empirical verification of hypotheses regarding the
vaccine B/R is based on real-world evidence about vaccines in elec-
tronic health record (EHR) databases. The extraction of information
from these resources would be straightforward if the information was
represented homogeneously, i.e., by a unique symbol (code, word, or
phrase) for each concept (vaccine or medical outcome). However, a
common characteristic of the post-licensure information resources is
their representational heterogeneity: the symbols used to represent
equivalent information differ between – or even within – resources. In
free-text resources such as UGC and scientific literature, differences
in descriptions may be due to the use of different natural languages,
terminologies, or levels of detail (e.g., vaccine products vs. pharmaco-
logical classes). In EHR databases, different coding systems are used
to represent medical information. This representational heterogeneity
encumbers the retrieval of vaccine-related information.
Automatic or semi-automatic methods promise to improve the ex-
traction of vaccine-related information from resources where repres-
entational heterogeneity occurs. Such automatic methods instruct a
computer to make sense of information independently of variance in its
representation – a process that generally involves three steps: (1) recog-
nizing the symbols that carry relevant information (e.g., specific words
in free text or codes in databases), (2) representing the information
independently from its symbols, and (3) interpreting the information
against the background of domain-specific knowledge. We refer to
this process as vaccine semantics. The pursued aim of post-licensure
vaccine management determines the steps required for the information
extraction, and the characteristics of the considered resources shape
the automatic methods implementing each step. The following sections
present the aims and relevant resources in more detail.
listening to safety concerns and public sentiment
The World Wide Web has developed in the past decade into an un-
precedented platform for forming interest communities and rapidly
sharing information. Its large volume makes UGC a promising resource
to monitor healthcare-related issues in the public. For example, the
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tapping of social media messages covering personal experience with
medical products has spawned much interest for using this informa-
tion for the surveillance of diseases and drug safety.16–23 Blogs and
MySpace discussions have been evaluated for safety surveillance of
vaccines,24,25 and UGC and public news were proposed for monitoring
public sentiment about vaccines and vaccinations programmes.26–28 It
is unknown, however, if or how an analysis of social media messages
can contribute to the surveillance of vaccine safety or to the monitoring
of public sentiment towards vaccines.
The use of social media messages for monitoring vaccine safety
and sentiment is challenging because social media represent secondary
data, i.e., data that are not originally intended for monitoring. Messages
are authored in different languages and vaccine descriptions differ by
idiom, terminology, and syntactic variations. To date, there are no
standard methodologies for mining social media content for vaccine
safety surveillance or monitoring of public sentiment. The field of
natural-language processing (NLP), however, provides general methods
for analysing natural language data and extracting information (see
explanation box 1.1).
accessing established evidence about vaccine b/r
Previously established evidence in the form of scientific literature
constitutes an important component in the B/R assessment of vaccines.
The amount of available scientific literature about human vaccines
grows rapidly: more than 3,000 publications about human vaccines are
made available on PubMed every year.29 The sheer amount of articles
hampers the manual screening of literature to retrieve study results
about a specific vaccine or a class of vaccines. Automatic retrieval of
specific vaccine information could help accelerating the post-marketing
assessment of vaccines and communicating established knowledge to
prevent or handle crises of public confidence in vaccination programs.
The retrieval of evidence about a vaccine from scientific literature
involves three tasks: (1) identifying articles that are relevant for a given
vaccine or vaccine class, (2) recognizing the vaccines in the text by
their descriptions, and (3) extracting relational information about the
vaccine, e.g., stated adverse events. However, the automatic retrieval
of vaccine-related information from scientific literature is challenging
due to the large syntactic variability in vaccine descriptions and their
semantic relations that is common in research articles.
Literature databases provide a classification of published articles
by indexing them with codes from a controlled vocabulary, such
as the Medical Subject Headings (MeSH) for the PubMed literature
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Explanation box 1.1: Natural-language processing
Natural-language processing (NLP) is a field of computer science and
artificial intelligence, where automatic methods are developed for pro-
cessing texts written in natural languages (such as English, in contrast
to formal languages that target computers). Potential applications of
NLP are information retrieval (the identification of relevant documents
in a corpus) and information extraction (the extraction of structured
information from a given document). NLP is challenging because the
flexibility of natural language and the ubiquity of domain-specific and
general background knowledge in human understanding opposes the
deterministic execution of computer programs.
NLP methods typically process the input text in a pipeline involving
several steps (and required steps depend on the task):
1. Sentence splitting: Identify the boundaries between sentences in
the input text to limit each subsequent step to one sentence.
2. Tokenization: Split each sentence in a sequence of words or punc-
tuation.
3. Lemmatization: Map words to their canonical form (lexeme) by
removing morphological variations, e.g., ‘goes’ → ‘go’.
4. Named-entity recognition (NER): Assign words or sequences of
words to entity types, e.g., ‘Aspirin’ → Drug.
5. Parsing: Syntactically analyse a sentence to generate a parse tree
over its words.
6. Normalization: Assign named entities to identifiers from a data-
base, ontology, or knowledge graph to connect them with contex-
tual information.
7. Semantic analysis: Extract semantic relations between normalized
entities that are described in the text (e.g., ‘Aspirin’ treats ‘pain’).
database.30,31 The classification constitutes an indispensable tool for
quickly identifying relevant literature. However, indexing is a manual
process and does not cover all recent publications.32 Also, articles are
indexed on a document level and the location of the text that led to the
indexing is not retained. This text location is a critical starting point for
the automatic extraction of relational information.
The identification of drugs in scientific literature has been the subject
of extensive research, but little attention has been given so far to the
identification of vaccines,33 which differs from and is more difficult
than drug identification due to the large syntactic variability in vaccine
descriptions. Whereas a drug tends to be referred to by its (product
or generic) name or by the name of its active ingredient, a vaccine is
typically characterized by its properties, for example its immunization
introduction 5
targets and immunization strategy (e.g., ‘monovalent conjugated vac-
cine against Haemophilus influenzae type B’). Available reference corpora
for medicines contain only few vaccine mentions,34 which prevents
their use in training or evaluating automatic methods for vaccines.
Relational information about vaccines in scientific literature includes
statements about the vaccine benefits (relating a vaccine with its vaccine-
preventable disease) and risks (relating a vaccine with a potential ad-
verse event). The manual relation extraction from scientific articles and
their storage in structured databases is cumbersome and expensive,
and existing inventories are fragmental.35 Automation of the extrac-
tion promises to solve these problems. Previous research on relation
extraction from scientific literature, however, largely focused on finding
interactions between genes, proteins, and drugs.36–44 General, auto-
matic recognition of vaccine descriptions in scientific literature has not
been attempted previously to the best of our knowledge. Attempts to
extract relations between chemicals, including drugs and vaccines, and
diseases have met with limited success, mostly due to the lack of a
large-scale training corpus.45
empirical verification of b/r hypotheses in observational
studies
After the approval of a vaccine, hypotheses about the vaccine B/R are
tested by conducting observational studies in EHR databases. These
studies generally aim at quantifying the effect of a vaccine exposure
on a medical outcome, i.e., on the vaccine-preventable disease in ef-
fectiveness studies, or on an adverse event in safety studies. The study
protocol describes the medical outcome in a case definition and the
exposure by product names or pharmacological classes. To extract an
exposure or a medical outcome from an EHR database, its description
has to be translated into a database query comprised of pertinent codes
from the database coding system (see explanation box 1.2).
To increase their statistic power, observational studies can be per-
formed in a collaborative fashion by combining information from mul-
tiple EHR databases.46 Medical outcomes, however, are recorded using
different medical coding systems in European EHR databases (fig-
ure 1.1),47 and vaccines are represented by product names and pharma-
cological classes using medical coding systems, drug coding systems,
or database-specific custom coding systems.48 The definition of the
database-specific extraction queries and their harmonization, which
is required to guarantee a consistent extraction of vaccinations and
outcomes between databases, constitutes an important bottleneck in
the conduction of collaborative observational studies in Europe.46,49,50
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Explanation box 1.2: Coding of medical information
Medical information in electronic health record (EHR) databases is
represented using codes from controlled medical coding systems (i.e.,
vocabularies). Different medical coding systems are used in European
EHR databases. For example, the disease pneumonia is represented in
by code R81 from the ICPC-2 coding system the Dutch IPCI database,
by codes 480, 481, 482.2, 482.3, 482.9, 483, 485, 486, and 487.0 from
ICD-9 CM in the Italian Lombardy Regional database, and by codes
J12 up to J18 from ICD-10 CM in the Danish Aarhus database. The
meaning of each code is defined by a short, textual description in the
coding system. Standardized medical coding systems use a taxonomic
hierarchy to subordinate more specific codes to more general codes.
Some EHR databases use additionally free text and database-specific
custom coding systems to record information that is not covered by
the medical coding system of the database.
Two fundamental approaches to harmonization exist: broadening the
definition given in the study protocol, or unifying the database codes
(figure 1.2). A common ad hoc broadening approach is the manual
mapping of the textual case definition to an individual extraction query
for each database, based on an iterative process directed by earlier
extraction results, results from the literature, and expert discussion.
This mapping approach, however, requires great manual effort and
does not reinforce consistency between queries. It was refined in the
EU-ADR project49,51 by using the Unified Medical Language System
(UMLS),52 a compendium of numerous medical coding systems in-
cluding those commonly used to record medical information in EHR
databases (explanation box 1.3). Diseases, symptoms, laboratory pro-
cedures, or tests were automatically identified in the case definition
and represented by abstract concepts (i.e., concept unique identifiers
(CUIs) from the UMLS). The list of concepts was manually revised in
an iterative process. Lastly, the concepts were automatically projected
into corresponding code sets from the targeted coding systems using
the assignments between concepts and codes in the UMLS. Whereas the
identification of concepts and their projection to codes was automatic,
the overall workflow was not integrated and the development process
was difficult to document, which hampered the reuse of the queries in
subsequent studies.
In the unification approach, the codes used in the databases are
mapped to one reference coding system that is used to define the out-
come or exposure in the study protocol. Unification is suitable also
for resolving heterogeneity in the representation of vaccines, which
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THIN:
Read-2
IPCI:
ICPC-2
RCGP:
Read-2
BIFAP:
ICD-9 +
local ICPC-2 +
free text
SIDIAP:
ICD-10 CM
SSI:
ICD-10 CM
AUH:
ICD-10 CM
ASLCR, Puglia, Lombardy:
ICD-9
Pedianet:
free text
KI:
ICD-10 CM
HPVCH:
ICD-10 CM
HSD:
ICD-9 +
free text
PHARMO:
ICD-9 CM
GePaRD:
ICD-10 GM
Figure 1.1: Examples for heterogeneous representation of medical outcomes in
European EHR databases
Study protocol
definition
Heterogeneous
DB representations
Broadening
Unification
Figure 1.2: Approaches to harmonizing extraction queries for databases with
representational heterogeneity
are often recorded using custom coding systems that lack mappings
to other coding systems. The automatic unification of codes can be
based on an analysis of the different components of the coding systems,
such as the code descriptors, the taxonomic hierarchy, and informa-
tion about the instances (e.g., the vaccine products that belong to the
pharmacological class represented by a code).54 Custom vaccine coding
systems, however, usually lack taxonomic hierarchies and information
about instances.48 The only information about vaccine codes that is
generally available are their descriptors, which use different languages,
different terminologies, different levels of description (i.e., products
and pharmacological classes), and different properties for describing
equivalent vaccines (e.g., by vaccine-preventable diseases as ‘tubercu-
losis vaccine’ or by active ingredient as ‘BCG’). Domain knowledge
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Explanation box 1.3: The Unified Medical Language System
The Unified Medical Language System (UMLS) is a compendium of
medical coding systems, which have been integrated by assigning
codes from different coding systems but with a common meaning
to one concept unique identifier (CUI). The UMLS contains more
than 3.6 million CUIs that connect 14 million codes from 154 coding
systems (in version 2018AA).53 Code descriptors and hierarchies from
the coding systems are preserved in the UMLS. Each CUI is further
assigned to one or more of 127 semantic types, which define broad
conceptual categories such Disease or Substance. The figure below
illustrates the information in the UMLS related to the CUI C0010200,
which represents the meaning of ‘cough’.
Codes Code descriptors
Cough
ICPC-2:
R05
Read CTv3:
Xe0qn
MeSH:
D003371
SNOMED-CT:
158383001
ICD-10:
R10
. . .
MedDRA:
10011224
Cough
ICPC-2:
‘Cough’
Read CTv3:
‘Observ. of Cough’
MeSH:
‘Coughs’
SNOMED-CT:
‘Coughing’
ICD-10:
‘Cough’
. . . :
‘Cough symptom’
MedDRA:
‘Coughing’
Taxonomic hierarchy Semantic types
Respiratory reflexAbnormal breathing Respiratory disorders
Cough
Evening cough Paroxysmal cough
Finding
Sign or
symptom
Laboratory
result
Biological
function
Organ
function Disease
about vaccines is required to resolve these representational differences
in the unification of the vaccine codes. A common way to make domain
knowledge available to automatic processes is its formalization in an
ontology (explanation box 1.4). However, existing vaccine ontologies
focus on vaccine products and their immunological properties and are
not suited to interpret vaccine descriptions.55
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Explanation box 1.4: Ontologies
In computer science, an ontology is a formal definition of the entities
in a domain including their relations (‘the explicit specification of a
conceptualization’).56,57 The entities in an ontology comprise (1) ground
level objects (e.g., vaccine products or packages), (2) properties that
describe a relation between two entities, and (3) classes that group other
entities by defining common characteristics (e.g., the class for influenza
vaccines contains any vaccine that immunizes against influenza) and
that are arranged in a taxonomic hierarchy (e.g., all influenza vaccines
are also viral vaccines). Different conceptualizations of a domain are
valid and an ontology always represents a specific point-of-view on
a domain. The de facto standard for describing ontologies is the Web
Ontology Language (OWL2).
The figure below exemplifies an ontology of vaccines, pathogens, and
diseases (solid arrows capture the taxonomic hierarchy, dashed arrows
indicate relations with their properties). The class BCG is defined as
a subclass of Tuberculosis vaccines, which in turn is defined as the
set of vaccines that immunize against Mycobacterium tuberculosis. The
relation is specified by the property immunizes against. The ontology
also formalizes the domain knowledge that Mycobacterium tuberculosis
is the causal agent of Tuberculosis. This information can be applied to
derive the fact that BCG is a vaccine that protects against Tuberculosis.
Vaccines
. . . Tuberculosis
vaccines
. . . BCG
Pathogens
. . . Bacteria
Mycobacterium
tuberculosis
Diseases
Bacterial
diseases
Tuberculosis . . .
. . .
immunizes
against
causes
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outline
This thesis explores automatic methods for solving representational
heterogeneity of vaccine-related information to facilitate post-marketing
benefit and risk assessment of vaccines (figure 1.3). Part I focuses on
public social media. Their use for the surveillance of vaccine safety
is evaluated in chapter 2, and for understanding the dynamics of the
public sentiment towards a vaccine in chapter 3. Both chapters present
basic methods for the identification and retrieval of relevant information
(vaccines, medical outcomes, and locations) from public social media
messages using different languages and terminologies. Part II covers the
retrieval of established knowledge from scientific literature. Chapter 4
compares different methods for recognizing vaccine descriptions in
scientific articles and for classifying articles by vaccines. Chapter 5
presents RELigator, a system that extracts causal relations between
chemicals and diseases from scientific articles, which could eventually
be specialized in the extraction of vaccine adverse events by combining
it with the automatic recognition of vaccine descriptions. Part III deals
with retrieval of vaccines and outcomes from electronic health records.
Chapter 6 presents CodeMapper, a comprehensive web application that
helps in broadening clinical definitions of medical outcomes to database
queries. And chapter 7 closes with a novel approach to unify vaccine
coding systems based on the VaccO ontology, which was created for
the purpose of representing and reasoning about vaccine descriptions.
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Part I
L I S T E N I N G T O VA C C I N E S A F E T Y
C O N C E R N S A N D P U B L I C S E N T I M E N T

2
S O C I A L M E D I A F O R VA C C I N E S A F E T Y
S U RV E I L L A N C E
abstract
objective To evaluate potential contribution of mining social media
networks for medicines safety surveillance using the following asso-
ciations as case studies: (1) rosiglitazone and cardiovascular events
(i.e., stroke and myocardial infarction); and (2) human papillomavirus
(HPV) vaccine and infertility.
methods We collected publicly accessible, English-language posts
on Facebook, Google+, and Twitter until September 2014. Data were
queried for co-occurrence of key words related to the drug/vaccine and
event of interest within a post. Messages were analysed with respect to
geographical distribution, context, linking to other web content, and
author’s assertion regarding the supposed association.
results A total of 2,537 posts related to rosiglitazone/cardiovascular
events and 2,135 posts related to HPV vaccine/infertility were retrieved,
with the majority of posts representing data from Twitter (98% and
87%, respectively) and originating from users in the US. Almost 25%
of rosiglitazone-related posts and 75% of HPV vaccine-related posts
referenced other web pages, mostly news items, law firms’ websites,
or blogs. Assertion analysis showed predominantly affirmation of the
association rosiglitazone/cardiovascular events (72%, N=1,821) and
of HPV vaccine/infertility (82%, N=1,753). There were only 10 posts
describing personal accounts of rosiglitazone/cardiovascular adverse
event experiences and 9 posts describing HPV vaccine problems related
to infertility.
conclusions Publicly available data from the considered social me-
dia networks were sparse and largely untrackable for the purpose of
providing early clues of safety concerns regarding the prespecified case
studies. Further research investigating other case studies and exploring
other social media platforms are necessary to further characterize the
usefulness of social media for safety surveillance.
Coloma PM, Becker BFH, Sturkenboom MCJM, van Mulligen EM, Kors JA. Evaluating
Social Media Networks in Medicines Safety Surveillance: Two Case Studies. Drug Saf 38
(2015)
15
16 social media for vaccine safety surveillance
2.1 introduction
The past decade has brought forth enormous growth and popularity
of online communities and social networks, greatly expediting inform-
ation exchange from one corner of the world to another. The concept
of blogging has allowed virtually anybody with internet access to post
his or her views and experiences on any topic at any time. Whilst
the value of such online conversations has been exploited mostly by
commercial enterprises to promote product improvement and innova-
tion, healthcare has not been immune to this phenomenon of public
engagement.59–61 In the same spirit of eliciting greater patient particip-
ation, several investigators have begun to explore what social media
can offer in terms of medicines safety surveillance.19,22,62 Reporting
of individual cases of suspected adverse drug reactions (ADRs) to
regulatory authorities, mostly by physicians or other healthcare pro-
fessionals, remains the cornerstone of pharmacovigilance. However,
spontaneous reporting systems are hampered by various limitations,
the most important of which is underreporting.63,64
Because social media represent secondary data, i.e., data that are not
originally intended for surveillance, there are challenges to overcome
with respect to terminology, traceability, and reproducibility. Apart
from these technical challenges, practical policy guidelines are lacking
on how potential safety signals from social media should be handled
in the current regulatory framework. Although the US Food and Drug
Administration (FDA) has released two guidance documents on the use
of social media platforms for presenting benefit/risk information on
prescription drugs and medical devices,65 these documents are more
concerned with product promotion than surveillance and ‘do not es-
tablish legally enforceable rights or responsibilities’.66 The European
Medicines Agency (EMA)’s guideline on good pharmacovigilance prac-
tices (Module VI) provides provisions on how to deal with information
on suspected adverse reactions from the internet or digital media and
hold market authorization holder (MAH) responsible for reviewing
web sites under their control for valid cases and reporting them accord-
ingly, although there is no requirement to trawl internet sites not under
the MAH’s control.67 To date there are no standard methodologies to
mine user-generated data from social media for pharmacovigilance.
In this study we sought to evaluate the potential contribution of min-
ing social media networks for pharmacovigilance using examples of
drug-event associations that have been flagged as potential signals:
rosiglitazone and cardiovascular events (i.e., stroke and myocardial
infarction); and human papillomavirus (HPV) vaccine and infertility.
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2.2 methods
Postings were collected from three of the most widely used social media
networking platforms (Facebook, Google+, and Twitter) using their
respective search application programming interface (API). The search
APIs return a set of public messages from the social network that match
the query keywords. For each message the content is provided together
with additional information about the message itself (date and content),
about the status in a conversation (repost or reply to another message),
and about author (user name and location). Messages were obtained
from as far back as available until 25 September 2014. Only English-
language posts were considered. Facebook provides only messages
from the preceding month by their search API. The search API of
Google+ obtains messages dating back to its establishment in 2011. The
search API of Twitter is restricted to a time window of about one week.
In order to supplement the Twitter data obtained via its search API, an
additional search engine, Topsy was used.68 Topsy is a real-time search
engine for posts and shared content on social media, primarily on
Twitter and Google+. As of this writing, Topsy had complete coverage
of historical messages and has indexed every (public) tweet ever posted
since 2006. For this particular study, only Twitter-related posts were
retrieved via the free analytics service of Topsy.
2.2.1 Case studies
Usefulness of the above social media platforms for safety surveillance
was evaluated using two examples of drug-adverse event associations
that have previously been flagged as potential safety signals: (1) rosiglit-
azone and cardiovascular events (i.e., stroke and myocardial infarction);
and (2) HPV vaccine and infertility. These two case studies were chosen
because they represent associations that have triggered controversies
and thus are likely to have been the subject of media attention as well
as online discussions. Furthermore, the case studies involve different
types of agents that are used by different subsets of the population
under different circumstances, thus allowing investigation of diverse
scenarios.
For each case study, data were queried for co-occurrence of the
drug/vaccine of interest and the event of interest within the same post
or tweet. Search queries were constructed using all possible drug-event
keyword combinations. Event-related keywords consisted of clinical
terms from the Unified Medical Language System (UMLS) as well as
known abbreviations and layman’s terms (search queries and event
keywords are available as online supplementary material69). Drug-
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related keywords consisted of international non-proprietary names and
trade names.
2.2.2 Assessment of suitability for use in safety surveillance
Relevant posts were tallied (reposts/retweets excluded) and analysed
with respect to geographical distribution, context, and linking to other
web content. The country of origin of a message was automatically
determined from the location information about the author. When the
country was not available in a designated data field, it was automatic-
ally identified from the available location information by means of a
list of names of countries, regions and cities. The frequency of message
propagation (i.e., reposts or retweets) was calculated. The content of
all posts were reviewed one by one to determine whether there was
reference to a person’s actual experience of having the (adverse) event
of interest in relation to exposure to the drug (or vaccine) of interest.
It was not the intention to assign or assess causality, but rather to
describe the context of how the drug-event relationship is described.
Posts were likewise analysed with respect to the author’s assertion
of the purported association between the drug (or vaccine) of interest
and the event of interest. Somewhat analogous to sentiment analysis,
assertion was judged as one of the following: (1) affirmative, if the post
alluded to an affirmation of the association; (2) negating, if the post al-
luded to a negation of the association; or (3) neutral, if the post alluded
to neither affirmation nor negation of the association. Manual review
and annotation of the assertions was done by a physician/pharmacist
(PMC). In addition, key dates during which important communication
or regulatory actions occurred were marked and compared with the
timeline of the posts.
2.3 results
2.3.1 Rosiglitazone and cardiovascular events
As shown in table 2.1, we retrieved a total of 2,537 posts related to
rosiglitazone and cardiovascular events (i.e., stroke and myocardial
infarction), with the overwhelming majority of posts (98%) representing
data from Twitter. There were only two posts on Facebook, while there
were 41 posts retrieved on Google+. About 10% of all posts were reposts
or retweets. The country of origin (based on the holder of the social
network account) could not be automatically identified in 59% of the
posts; of the posts that could be identified, two-thirds was accounted for
by the United States (US) while the remaining one-third was distributed
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Table 2.2: Description of web pages referenced by posts about rosiglitazone
and cardiovascular events
Category of linked
web pages
Facebook
(N=2)
Google+
(N=41)
Twitter
(N=493)
Total
(N=536)
News - 8 (20%) 188 (38%) 196 (37%)
Law firm’s website
or advertisement
1 (50%) 17 (41%) 139 (28%) 157 (29%)
Blog - 13 (32%) 125 (25%) 138 (26%)
Health reference for
professionals
- 2 (5%) 22 (5%) 24 (5%)
Patient community
website
- - 2 (1%) 4 (<1%)
Health education for
patients
1 (50%) - - 1 (<1%)
Scientific journal - - 15 (3%) 15 (3%)
Video - 1 (2%) - 1 (<1%)
among 50 other countries or territories all over the world. Overall, 21%
of posts (N=536) had links to other web pages (table 2.2). News items
comprised more than one-third of the web pages referenced (N=196),
followed by law firms’ websites or advertisements (N=157) and blogs
(N=138). There were 24 posts referring to health information websites
intended for health professionals, 15 posts linking to scientific journals,
four posts referring to a patient community website, one post linking to
a hospital’s patient education website and another to a YouTube video.
Assertion analysis done on all posts demonstrated predominantly
affirmation of the association between rosiglitazone and cardiovascular
events (72%, N=1,821), with the remainder more or less split between
negating (13%) and neutral (15%). Most neutral posts were asking
for further information or otherwise not directly related to the drug-
adverse event association. There were posts by lawyers or reporters
explicitly soliciting cases (N=12), but there were also posts (N=122)
ridiculing lawyers’ television commercials that asked patients who
‘died while taking the drug’ to call a particular number.
Figure 2.1 shows the trend of assertions over time in relation to
events in the timeline of the association of interest. The highest peak of
affirmative posts occurred in February 2010. In this particular month,
the US Senate Finance Committee released a report based on a two-
year inquiry of rosiglitazone, expressing concern that ‘FDA has over-
looked or overridden safety concerns cited by its own officials’.70 The
EMA’s suspension of rosiglitazone’s marketing authorization in the
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Figure 2.1: Trend of assertions of rosiglitazone/cardiovascular event-related
posts over time.
European Union (EU) and the FDA restriction of access to the drug
coincided with the second peak of affirmative posts in September
2010, while the simultaneous publication in high-impact journals of
two studies demonstrating increased cardiovascular risk with use of
rosiglitazone71,72 coincided with the peak in June 2010. The peaks in
negating assertions paralleled those of the affirmative, with the greatest
peak in affirmations observed in June-July 2010 (and a smaller peak
in November 2013), reflecting the active online debate that was hap-
pening regarding the issue. Figure 2.1 also shows that in June 2013
negating posts actually outnumbered the affirmative posts; the results
of the FDA-mandated re-evaluation of the rosiglitazone (RECORD)
trial became available online in June 2013.73 The peak of neutral posts
seen in July 2011 represented posts about news of rosiglitazone being
potentially useful for neuropathic pain (although the pertinent study
was already published online three months earlier74).
There were only 10 posts that appeared to be about experiences
of the drug-adverse event association of interest. Four posts involved
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the person posting the message himself or herself (one even claimed
winning a legal case against the drug manufacturer); three involved
somebody’s brother-in-law; while there was one each for somebody’s
father, father-in-law, and grandmother. In addition, there were two
posts referencing a patient community website that claimed 21,015
people reported to have a heart attack while taking rosiglitazone (rep-
resenting ‘32% of all who reported side effects’). Interestingly, some
posts (N=20) alleged other adverse events of rosiglitazone such as leg
pain, abdominal pain and eye pain (all of which are symptoms suggest-
ive of end-organ complications of diabetes, the primary indication for
the drug), while others (N=67) alluded to a beneficial effect of the drug
(prevention of neuropathic pain).
2.3.2 HPV vaccine and infertility
We retrieved a total of 2,135 posts related to HPV vaccine and infertility,
again with the majority of posts (87%) representing data from Twitter
(table 2.3). There were 23 posts on Facebook while there were 256 posts
retrieved on Google+. Reposts or retweets comprised 22% of all posts.
Similar to posts related to the previous case study on rosiglitazone,
the country of origin was unknown for more than half of the HPV
vaccine-related posts, with the US representing majority (N=519) of
those posts that could be automatically identified. In contrast to the
rosiglitazone-related posts, however, a large proportion of all posts
(84%) referenced other web pages (table 2.4). Various blogs comprised
almost half of the linked web pages referenced (N=847), followed by
news items (N=650) and scientific journals (N=118). Most of the blogs
commented on these same news items or journal articles. There were
109 posts referring to health information websites intended for health
professionals, 49 posts linking to (mostly anti-vaccine) YouTube videos,
while only a minority of posts were associated with lawyer’s websites
or advertisements (N=24).
The posts demonstrated predominantly affirmative assertion of the
association between HPV vaccine and infertility (82%, N=1,753), with
posts that negate the association accounting for 4% (N=81) and neutral
posts accounting for the rest. Most neutral posts were asking for fur-
ther information or were negative comments about the HPV vaccine
in general but not directly related to infertility. Figure 2.2 shows the
trend of assertions over time in relation to events in the timeline of the
association of interest. The highest peak of affirmative posts occurred
in November 2013 when two sisters, aged 20 and 19, alleged at a US
federal court that Gardasil (trade name of the HPV vaccine) caused
them to go into early menopause and become infertile. The build-up to
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Table 2.4: Description of web pages referenced by posts about HPV vaccine
and infertility
Category of linked
web pages
Facebook
(N=15)
Google+
(N=249)
Twitter
(N=1,538)
Total
(N=1,802)
News 4 (27%) 121 (49%) 525 (34%) 650 (36%)
Law firm’s website
or advertisement
- 3 (1%) 21 (1%) 24 (1%)
Blog 5 (33%) 100 (40%) 742 (48%) 847 (47%)
Health reference for
professionals
- 8 (3%) 101 (7%) 109 (6%)
Scientific journal - 1 (<1%) 117 (8%) 118 (6%)
Video 1 (7%) 16 (6%) 32 (2%) 49 (3%)
Multiple sites 5 (33%) - - 5 (<1%)
this peak appears to have been triggered by a study describing three
young women who presented with secondary amenorrhea following
HPV vaccination;75 this study was first published online at the end of
July 2013 (corresponding to the earlier, but smaller, peak in figure 2.2).
Many of the posts within the period from August to October 2013 actu-
ally referred to an event that happened one year before: the publication
of the first case report on the association of interest. This case report of
a 16-year-old Australian girl who had premature ovarian failure after
HPV vaccination was first published online in October 2012.76
There were nine posts that appeared to be accounts of HPV vaccine-
adverse event experience. Six posts involved the person posting the
message herself. One simply said she was ’15 and infertile’ because of
the vaccine (the actual page appears to have been taken down after the
initial data collection), while four other individuals claimed to have an
ovarian cyst, delayed period (and negative pregnancy test), (vaginal)
spotting, menopause and hot flashes because of the vaccine. One post
was about somebody’s friend who was ‘21 and infertile due to the
HPV vaccine’ and there were two posts from different mothers whose
daughters had no (menstrual) periods after getting the vaccine.
2.4 discussion
In this study we aimed to characterize the data currently available from
social media networking platforms and to determine if – and how –
such data can be tapped for surveillance of two specific safety issues:
rosiglitazone and cardiovascular events (i.e., stroke and myocardial
infarction); and HPV vaccine and infertility. Rosiglitazone is a drug
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Figure 2.2: Trend of assertions of HPV vaccine/infertility-related posts over
time.
indicated for a very prevalent disease, diabetes, and although such
a disease is expected to occur in the middle-aged population – who
comprise a relative minority of the population of Twitter users, it was
precisely one of the aims of this study to illustrate that such a group
and such condition of interest could be under-represented in social
media networks, however huge these networks may be. The primary
motivation for exploring social media as an additional resource for
pharmacovigilance is to capture information that cannot be found
in traditional sources. Among the three websites evaluated, Twitter
provided the greatest number of (publicly available) posts potentially
relevant to the two case studies but these represented mostly links
to news items or, particularly for rosiglitazone and cardiovascular
events, websites of personal injury lawyers rather than accounts of
drug/vaccine-related adverse events. The ubiquity and instantaneous
nature of the internet and social media networks supposedly provides
a mechanism to find adverse drug (or vaccine, or medical device)
experiences of laymen that are otherwise missed by ADR reporting
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systems – and in real time. Thus, one of the more relevant questions
to ask is whether data from social media networks can provide early
signs of potential safety concerns. Despite the hype about social media
representing ‘big data,’ the volume of relevant posts was sparse for
the two case studies considered. Although Twitter has over 500 million
users (more than half of whom are reportedly active), it was too ‘young’
a source to use, particularly for the case study on rosiglitazone. When
FDA issued the safety alert on Avandia in May 2007 Twitter had only
been in service for less than a year, was largely in its trial phase and thus
still had few subscribers. The same argument can be said for Facebook,
which became available in September 2006 and Google+, which was
launched much later in September 2011. The problem that these social
media sites did not have enough time to accumulate data should have
been less of an issue for the HPV vaccine-infertility association, which
is a more recent potential safety concern, and yet that does not seem to
be the case.
Our findings corroborate what other researchers have shown regard-
ing the geographic distribution of users of social media networks: a
small number of countries, led by the US, account for a large share of
the total user population and likewise make up the active and influen-
tial user population.77,78 Although this is not totally unexpected, given
that only English-language posts were obtained in this study, there can
be implications on inferences drawn from research using data from
social media networks.
There were (only) 10 and 9 accounts of adverse experiences related
to rosiglitazone/cardiovascular events and HPV vaccine/infertility, re-
spectively, but these experiences appeared to be more reactionary than
anticipatory (meaning they were shared online after news about the
safety issues broke out). Furthermore, verification of such allegations
proved to be difficult considering the data privacy constraints (only
publicly accessible data could be analysed) and in particular, estab-
lishing an identifiable patient and ‘reporter’ (required for valid safety
reporting in traditional pharmacovigilance systems) is challenging, if
not impossible. The scenario of unprincipled individuals spreading
inaccurate – and even false - information is not unheard of and since
social media is largely unregulated, cannot be avoided.79 Interestingly,
two posts identified in the current study referenced a health inform-
ation and community website,80 which claims to have studied (as of
the time of writing this article) ‘65,460 people who had side effects
while taking Avandia from FDA and social media,’ and among them
21,015 had a ‘heart attack’. In addition, there are 7,752 who had ‘stroke’.
The website provides statistics on when the heart attack/stroke was
reported, age and gender of people who have heart attack/stroke
when taking Avandia, ‘time on Avandia when people have heart at-
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tack/stroke,’ ‘severity of heart attack/stroke when taking Avandia,’
‘top conditions involved for these people,’ and ‘top co-used drugs for
these people.’ All such information – if truthful – are relevant. However,
nowhere is it stated which part of the information comes from social
media and specifically from which social media (there are too many of
them). More importantly, there is no description of how these reports
were obtained, the actual configuration and content of the reports could
not be traced, and the circumstances surrounding the alleged adverse
events could not be verified. While the site does include a general dis-
claimer and a counsel to ‘report adverse side effects to the FDA,’ these
sections are found at the end of the page and may be easily ignored.
White et al. utilized retrospective web search logs to make the case
for internet users providing early clues about adverse drug events via
their online information seeking.18 Chary et al. have proposed tools
for using data from social networks to characterize patterns of (recre-
ational) drug abuse,81 while Harpaz et al. have provided an extensive
review on how state-of-the-art text mining for adverse drug events
can leverage unstructured data sources, including social media.82 Sim-
ilar to the current study, Freifeld et al. used publicly available data
from Twitter to obtain messages that resembled adverse event reports
(‘proto-AEs’) related to 23 prespecified medical products.19 Rather than
focusing on a few specific events of interest, the Freifeld study collected
all potential events (symptoms), thus resulting in more permutations of
search terms, which explains why their study had a higher yield of rel-
evant posts compared to our study. While our current study was more
of a ‘scoping’ study across three social media networking platforms
for two specific case studies, the study by Freifeld et al. had a different
aim: to evaluate concordance between Twitter posts mentioning AE-
like reactions and spontaneous reports received by the FDA Adverse
Event Reporting System (FEARS). There is the implicit assumption of
equivalent level of information between the two sources, which, among
other things, necessitated the development of a dictionary to map in-
ternet vernacular to the standardized ontology Medical Dictionary for
Regulatory Activities (MedDRA). Other researchers have explored the
utility of more specific health-oriented websites and patient community
forums to identify adverse drug events83 and to better understand the
impact of ADRs.84 These types of social media sources are likely to
provide more relevant content because their very nature allows for shar-
ing of health-related concerns among patients with similar conditions
(‘like me’) and would make verification easier since user registration
is often mandatory and more exhaustive (the likelihood of faking an
illness in this group is probably lower). Personal accounts of adverse
events from such sources are often inaccessible to the public, although
many of the prominent and moderated patient community websites
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will allow access to further information under certain conditions of use
(and sometimes for a fee). These more health-oriented social media
platforms are certainly worth exploring, especially for surveillance of
uncommon adverse events as well as those related to drugs indicated
for rare conditions.
The potential value of mining data from social networks appears to be
greatest for measuring awareness regarding potential safety concerns.
Because this study focused only on English-language posts, there is the
caveat that the findings are biased towards users from English-speaking
countries, particularly the US, that comprise the majority of subscribers
of these social networking sites. Both number of posts and assertion
trend in the two case studies were predominantly driven by events
that occurred in the US. Another caveat is that bad news is often more
popular than good news. The case report of the 16-year-old girl from
Australia who had premature ovarian failure after HPV vaccination
fired up huge comments online while four studies (published earlier
or around the same time)85–88 that showed no evidence of increased
risk for new adverse events, including those related to fertility, were
practically ignored.
The other, perhaps even more relevant, question to ask is whether
data from social media networks can be used to help corroborate, or
refute, potential safety concerns by providing information where there
is none. It is time to turn the impressionability of social media as an
advantage and leverage it towards bringing balanced and evidence-
based information to the internet and its multitude of users.
2.4.1 Limitations
Data were queried for co-occurrence of the drug/vaccine of interest
and the event of interest within the same post or tweet, which may
have limited the number of relevant posts obtained. Similarly, the use
of publicly available data and English-language only posts may have
contributed to sampling bias. The assertion analysis conducted may not
always reflect the true opinion of the user, the very nature of social me-
dia promoting an open and unrestricted environment. A generalization
cannot be made as to which among the social networking platforms
provides the most valuable information since the amount and nature of
commentaries generated and shared within each network is a function
of its own culture and privacy restrictions. Moreover, the population
of users of social networking sites comprises the relatively young (and
healthy) and fairly educated who have access to internet.89–91 The eval-
uation done was retrospective and the findings for these particular
case studies considered may not necessarily reflect discussions about
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safety concerns related to other drugs or other vaccines in the future.
Because social media platforms are continually being re-engineered
to improve the commercial service, there is the concern as to whether
studies conducted on data collected from these platforms are reprodu-
cible, even one year later.92 The phenomenon of ‘blue team dynamics’
has been described where the algorithm generating the data (and, con-
sequently, user utilization) has been modified by service providers such
as Google, Twitter, and Facebook in line with their business model.92,93
Similarly, there is the so-called ‘red team’ dynamics, which occurs when
social media platform users attempt to manipulate the data-generating
process to support their own economic or political gain.92,94
2.5 conclusions
Publicly available data from the considered social media networks were
sparse and largely untrackable for the purpose of providing early clues
of safety concerns regarding the prespecified case studies (rosiglitazone
and stroke/myocardial infarction and HPV vaccine and infertility).
The potential value of mining data from social networks appears to
be greater for measuring awareness regarding emerging safety issues,
with the caveat that this will be biased towards a younger and healthier
population who comprise the majority of subscribers of these social
networking sites. Further research investigating other case studies
(including prospective investigations) and exploring other social media
platforms are necessary to further characterize the usefulness of social
media for post-marketing safety surveillance.

3
S O C I A L M E D I A F O R F O L L O W I N G A VA C C I N E
D E B AT E
abstract
background Public confidence in an immunization programme is a
pivotal determinant of the programme’s success. The mining of social
media is increasingly employed to provide insight into the public’s
sentiment. This research further explores the value of monitoring social
media to understand public sentiment about an international vaccina-
tion programme.
objective To gain insight into international public discussion on
the paediatric pentavalent vaccine (DTP-HepB-Hib) programme by
analysing Twitter messages.
methods Using a multilingual search, we retrospectively collected
all public Twitter messages mentioning the DTP-HepB-Hib vaccine
from July 2006 until May 2015. We analysed message characteristics
by frequency of referencing other websites, type of websites, and geo-
graphic focus of the discussion. In addition, a sample of messages was
manually annotated for positive or negative message tone.
results We retrieved 5771 messages. Only 3.1% of the messages were
reactions to other messages, and 86.6% referred to websites, mostly
news sites (70.7%), other social media (9.8%), and health-information
sites (9.5%). Country mentions were identified in 70.4% of the messages,
of which India (35.4%), Indonesia (18.3%), and Vietnam (13.9%) were
the most prevalent. In the annotated sample, 63% of the messages
showed a positive or neutral sentiment about DTP-HepB-Hib. Peaks
in negative and positive messages could be related to country-specific
programme events.
conclusions Public messages about DTP-HepB-Hib were character-
ized by little interaction between tweeters, and by frequent referencing
of websites and other information links. Twitter messages can indirectly
reflect the public’s opinion about major events in the debates about the
DTP-HepB-Hib vaccine.
Becker BFH, Larson HJ, Bonhoeffer J, van Mulligen EM, Kors JA, Sturkenboom MCJM.
Evaluation of a Multinational, Multilingual Vaccine Debate on Twitter. Vaccine 34 (2016)
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3.1 introduction
Vaccination programmes are among the most effective means for im-
proving population health. But particularly at the time of programme
introduction, they tend to be accompanied by public discussion.27,96
This may increase public awareness of the vaccine and affect the pro-
gramme beneficially.97 However, public concern may lead to reduced
uptake or even jeopardize the entire immunization programme.98,99
Therefore, detecting changes in public sentiment early is important to
understand its origin and dynamics and to inform appropriate meas-
ures to investigate concerns, guide public health decision making, or
help identify issues with the vaccine or the vaccination programme.
Public attention and sentiment about vaccines have been evaluated
previously by analysing different types of social-media messages and
user-generated web content. Messages from the social-media platform
MySpace were used for monitoring public sentiment about the human
papillomavirus (HPV) vaccine.24 Public news items about the HPV
vaccine were shown to influence the public’s awareness and opinion
about HPV infection and vaccine in the United States (US).25 Sentiments
about an influenza vaccine shared through Twitter messages were
found to correlate highly with US vaccination rates as reported by the
US Centers for Disease Control and Prevention (CDC).26 International
debates about vaccines and the course and drivers of public confidence
have also been studied through analysis of media sources such as
news sites, blogs, and governmental reports.27,28 Twitter and other
social media have frequently been used for post-marketing surveillance
of pharmaceutical safety issues.19,21,22 Some studies have concluded
that monitoring social media is more suitable for measuring public
awareness of known safety issues than for providing clues about new
safety signals (see chapter 2).58
Since 2001, a pentavalent paediatric vaccine against diphtheria, tetanus,
pertussis, hepatitis B and Haemophilus influenzae type b (DTP-HepB-
Hib) has been introduced into more than 70 low- and middle-income
countries.100 In a number of countries, the introduction of the vaccine
was accompanied by a critical debate following a suspected association
with the death of children, none of which have been deemed as causally
related to the vaccine.101 In India, a petition and a lawsuit was filed
against the vaccine.15,102 In Sri Lanka, Bhutan, and Vietnam, the market
authorization for the vaccine was even temporarily suspended.103
In this study, we explore the value of public Twitter messages to gain
insight into the multinational debate on the pentavalent vaccine.
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3.2 methods
3.2.1 Data collection
The search query ‘pentavalent OR pentavac OR quinvaxem’ was used
to retrieve messages about the pentavalent vaccine. The query terms
were selected to retrieve messages from multiple national discussions
about the vaccine, but not from all national or language-specific dis-
cussions (which would have required, amongst others, the inclusion
of country-specific brand names and slang terms). The terms ‘penta-
vac’ and ‘quinvaxem’ are brand names of the pentavalent vaccine and
specific to the vaccine as such. The term ‘pentavalent’ is also used
in various other contexts (e.g., ‘pentavalent’ also occurs in chemistry
and as user name on social media). To remove unrelated messages,
a message retrieved by the term ‘pentavalent’ was only retained if it
also contained the term ‘child’ or ‘vaccine’ (in the language of the mes-
sage). The translations of ‘child’ and ‘vaccine’ in different languages
were retrieved from OmegaWiki, a community-driven, multilingual
dictionary.104 OmegaWiki provided 94 terms for ‘child’ and 45 terms
for ‘vaccine’. The terms came from 67 different languages.
We used Twitter’s advanced search web interface to collect messages
retrospectively. The messages were collected on 1 May 2015. The ad-
vanced search interface provides the content and date of messages
from the entire history of Twitter since 2006. We queried Twitter’s web
application programming interface (API) to retrieve additional data
fields describing the language of the content, the identity of the author,
the geographical location in his or her user-profile, and the interaction
status of the message (original post, repost, or reply).
3.2.2 Message analysis
A random sample of 10% of the messages was selected for manual
analysis. The message tone was manually analysed to gain insights
into the sentiment about the pentavalent vaccine as reflected on Twitter.
The two categories of message tone – positive/neutral and negative – and
the criteria to assign the categories were the same as in a related study
about public news.28 A message was coded negative if it contained
any indication of concern about the pentavalent vaccine or vaccination
programme, e.g., information about an adverse event that occurred
after immunization, vaccine suspension, or any other factor that might
have a negative effect on the vaccine programme. A message was coded
positive/neutral if it contained no indication of public concern about
the vaccine or vaccination programme. Non-English messages were
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translated using Google Translate while annotating.105 Google Translate
covered the languages of all messages in the sample, and the tone was
apparent from the translations for all messages.
All authors of the messages in the random sample and the 50 au-
thors creating most messages overall were characterized as private per-
son, news site, health information, health organization, government, vaccine-
critical, manufacturer, or non-governmental organization (NGO) based on
their public Twitter profile.
To characterize the use of references (web links) in the collected
messages, the most commonly referred (top-level) web domains were
categorized as news site, social media, health information, health organiza-
tion, and other. Additionally, all messages from the random sample that
contained references, were manually assessed if the author added own
content (i.e., if the message contained more than a link to or the title of
the referred website).
We defined the geographical focus of a message by identifying the
countries mentioned in the message or referred web pages. A diction-
ary of terms for geographical entities of countries (including cities and
regions) was compiled from the GeoNames database to identify men-
tions of countries automatically.106 To disambiguate terms that referred
to entities in different countries, the country with the entity that had
the largest population was selected. For example, ‘Bali’ is the name of
a city in India and an island in Indonesia. Because the population of
the Indonesian island is larger than that of the Indian city, mentions of
‘Bali’ were assigned to Indonesia. Messages that contributed to peaks in
the message distribution over time were manually reviewed to identify
the events that triggered the peaks.
The messages were analysed for occurrences of the standard format
for reposts (‘RT @user’) to complement the information provided by the
Twitter API. However, when evaluating public awareness and sentiment
we did not distinguish between original posts and reposts, assuming
that users primarily repost messages that reflect their own stance.
3.3 results
We retrieved 7,657 messages about the pentavalent vaccine from Twitter,
of which 5,771 (75.3%) from 2,945 users remained after disambiguation.
The number of messages grew over the years from 10 messages in 2008
to 2619 messages in 2013 (32 in 2009, 110 in 2010, 446 in 2011, and
1,033 in 2012). The numbers of messages should be seen against the
background of a strong growth of Twitter messages until 2012, as well as
the expanded introduction of the pentavalent vaccine and incidents of
public resistance in some countries. After 2013 the number of messages
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declined (1,091 in 2014 and 430 until May 2015). A histogram of all
messages per month from 2012 until May 2015 is shown in figure 3.1 a).
In the manually annotated sample of 585 messages, 9 messages (1.5%)
were false positives of the message retrieval and filtering and unrelated
to the pentavalent vaccine. Among the 576 messages referring to the
pentavalent vaccine, 37% had a negative tone and 63% of the messages
had positive/neutral tone. The percentage of negative messages in the
random sample reached its maximum in 2014 (2010: 9%, 2011: 24%,
2012: 19%, 2013: 43%, 2014: 51%, 2015: 36%) when reports of alleged
cases of severe adverse events in Vietnam dominated the overall debate.
The striped bars in figure 3.1 a) show the estimated number of messages
with negative tone. No personal experience reports with the vaccine
were found in the manually annotated messages.
Figure 3.2 shows the distribution of users from the random sample
and of the top-50 tweeters over the user categories. In both sets most
users were private persons or represented news sites. Health informa-
tion sites, health organizations (including Global Alliance for Vaccines
and Immunization (GAVI), World Health Organization (WHO), and
CDC), governments, and vaccine-critical forums were overrepresented
among the top-50 users. Many users (N=1,979; 67.2%) created only
a single message, 920 users (31.1%) created 10 or less messages and
the 50 users with the largest number of messages (1.7%) each created
between 10 and 113 messages.
The dictionary of geographic entities contained 19,096 terms for 246
countries in 125 languages, with a median of 51 terms per language. In
total 135 terms (0.7%) referred to entities in different countries and were
disambiguated by population size. After a preliminary identification of
countries, 78 terms were removed from the dictionary because the terms
did not refer to geographical entities. Overall, 149 different countries
were identified in 4,067 (70.4%) of the messages. The most frequently
mentioned countries were India (2,047; 35.4%), Indonesia (1,056; 18.3%),
Vietnam (803; 13.9%), and Pakistan (631; 10.9%). Most countries (104)
were identified in less than 1% of the messages.
The most common languages of the messages were English (61.3%),
Indonesian (16.1%), and Vietnamese (7.1%). English occupies a spe-
cial role as the most common language on Twitter and as a common
language for public communication in India. Countries were most fre-
quently detected in Indian messages (79.2%), English messages (60.0%),
French messages (44.4%), and Vietnamese messages (35.0%). Multiple
countries were mentioned in 36.9% of the messages.
The country of origin could be identified by the information about
the author for 3,067 (53.1%) messages. Most authors came from India
(849; 27.6%), Indonesia (505; 16.4%), US (458; 14.9%), and Vietnam (267;
8.7%). The relationship between the country of the message author and
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Figure 3.1: Number of messages about the pentavalent vaccine from January 2011 until
April 2015 by month, with the estimated portion of messages with negative tone
as striped bars. a) All messages, b) India, c) Indonesia, d) Vietnam, e) Pakistan.
Messages between 2008 and 2010 (N=152; 2.6%) are not shown for clarity of the
figure.
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Table 3.1: The relationship between the country of the message author and
the country mentioned in the message content. Each cell contains
the proportion of messages by authors from the country on the row,
which mention the country in the column in their content (e.g., 74.3%
of the messages from users in India are about India).
Content
Author IN ID VN PK LK US BT SR JP KR
IN 74.3 2.6 11.2 15.5 14.7 6.4 14.0 0.6 3.8 0.8
ID 2.6 83.2 0.8 0.2 0.2 8.3 0.2 34.9 10.3 0.0
US 41.5 6.3 17.9 13.1 13.5 18.1 12.7 0.4 5.7 8.5
VN 4.5 0.4 45.3 5.2 7.1 0.7 5.6 0.0 1.5 11.2
the country mentioned in the message content is shown in table 3.1.
Each cell contains the proportion of messages by users from the country
on the row, which mention the country in the column. The figure shows
that authors largely focus on their own or neighbouring countries. Most
messages from the US – which contributes the largest number of Twitter
users but where the pentavalent vaccine was not a recently introduced
vaccine – referred to events in India.
Only 158 messages (2.7%) were replies to other messages, and 180
messages (3.1%) were reposts. References to websites were very com-
mon, as 86.6% of the messages contained at least one reference. In the
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manually annotated sample, the users provided original content in only
15.2% of the messages. The remaining messages only contained a link
or copied content of the referred page. The most frequently referenced
web domains were newspapers (70.7%), social media (9.8%), health
information sites (9.5%), and health organizations (9.3%).
Most peaks of messages in figure 3.1 a) could be attributed to peaks
of messages in individual countries, which in turn were in temporal
relation to country-specific events as annotated in figures figure 3.1
b-e). Messages from India in December 2011 discussed the introduction
of the pentavalent vaccine in the states Tamil Nadu and Kerala, and in
May 2012 the introduction in five other states. The discussion about
the vaccine gained momentum in India in 2013. Messages in January
2013 referenced news articles about child fatalities supposedly related
to the pentavalent vaccine. The messages in April 2013 discussed the
introduction of the pentavalent vaccine in eight more Indian states,
but also criticized a supposed re-labelling of expired vaccines. The
discussion between August and October 2013 included voices demand-
ing the ban of the vaccine and continued discussions about the child
fatalities. Numerous messages from February 2014 referred to articles
alleging the association of the vaccine with child fatalities. Messages
from May 2014 referred to the prequalification of a new brand of the
pentavalent vaccine by the WHO. The messages from October and
November 2014 discussed the introduction of the vaccine in the state
of Rajasthan. Numerous news items in January, April, September and
October 2013 primarily addressed the vaccination programme in India
but also mentioned the vaccination programmes in Vietnam, Pakistan,
and Sri Lanka, resulting in message peaks in the latter countries.
The messages about Indonesia in March 2012, August 2013 and
December 2014 were composed of references to a few news articles
discussing the production and introduction of the pentavalent vaccine
in Indonesia. The messages in May 2013 discussed the suspension
of the vaccination programme in Vietnam. Messages about Vietnam
in November 2013 referred mainly to news items alleging (severe)
adverse effects of the vaccine. In Pakistan the pentavalent vaccine was
introduced in late 2014 and the November messages reference news
articles about the introduction. The messages from Pakistan in March
2015 discussed the suspension of a health official for having spoiled
the national pentavalent vaccine supply due to inappropriate storage.
3.4 discussion
In this chapter, we conducted an analysis of Twitter messages to char-
acterize multinational debates about the pentavalent vaccine and vac-
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cination programmes. We combined an analysis of geographical focus
of the messages and message tone over time.
The debates on Twitter were portrayed by peaks of messages covering
events in country-specific vaccination programmes. The perceptions
of events on Twitter were local: authors of messages were largely
reacting to events in their own country or neighbouring countries,
suggesting multiple national debates rather than a multinational debate.
In contrast to a previous study that observed a broad variety of concerns
about vaccines in news sites, blogs and governmental reports,28 the
dominant concern in our data was about the safety of the vaccine. Most
messages were created by users representing private persons and news
sites. Stakeholders in the vaccination programme were overrepresented
among the 50 users who created the largest number of messages, which
suggests that they adhered longer to the debate than private persons.
The Twitter messages had three salient properties that have also been
observed in chapter 2: few interactions (replies, reposts) between users,
virtual absence of personal reports (in our case about the vaccine), and
frequent references to other websites, particularly news portals. Many
messages were comprised of only a reference or the title of the referred
website. This appears to indicate that the messages were mainly created
by sharing content on social media rather than to communicate with
other users in the social network, a pattern that was also observed in
Twitter messages about a measles vaccine in the Netherlands.107 These
properties can at least partially be explained by the focus of this study
on messages that were made publicly viewable. Sharing of personal
vaccine experiences and user interaction may be more common in
private messages but private messages were unavailable in our data
set.
With the lack of personal reports about the vaccine, our data does
not directly reflect the public’s opinion about the vaccine issues or
events. But the Twitter messages may, however, reflect the users’ opin-
ion indirectly: the fact that no additional content was added by the
authors of the large majority of Twitter messages suggests that the
authors generally concur with the referenced content. The question
whether messages on Twitter can shape public opinion was not in the
scope of this study, but other studies argue that clear and transparent
communication about vaccines, e.g., through social media like Twitter,
can improve uptake rates.96,97
The analysis of Twitter messages for evaluating public sentiment may
constitute a bias towards a debate between relatively young people
with internet access.89 This age group corresponds precisely to young
parents who decide whether or not the pentavalent vaccine should
be administered to their children. The population bias in this study
represents a focus on persons for whom the vaccination programme is
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potentially relevant. While most Twitter users are from the US, many
countries where the pentavalent vaccine has been introduced have
significant numbers of Twitter users.77
Our study has some limitations. First, the pentavalent vaccine has
been marketed with various other brand names that were not used as
query terms in this study. The inclusion of further brand names into the
search query could help to expand the study to more countries where
there are national debates about the vaccine (e.g., the scope of the
study could be expanded to the vaccination programme in Ukraine by
including the local brand name Pentaksim). However, we do not expect
the characteristics of Twitter messages as described above to differ
significantly in other countries. Second, the disambiguation of terms
for countries based on population sizes may result in misallocations
and could be improved by taking the context of the mention in the
message into account. Third, we automatically detected countries in
messages but did not try to determine whether a country mention was
vaccine-related. The analysis of geographical focus in the debate could
be further refined by distinguishing between country mentions that are
related to the vaccine and those that are not.
3.5 conclusion
The continuous monitoring of public debates about vaccines can help to
alert vaccination programmes to emerging issues that may cause public
confidence to plummet. We showed the potential value of monitoring
social media retrospectively based on manual analysis of messages.
When applying automatic techniques for the analysis of tone and topic
of messages, the presented approach could increase the capacity and
speed to allow for real-time analysis of public vaccine debates.
Part II
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AU T O M AT I C R E C O G N I T I O N O F VA C C I N E
D E S C R I P T I O N S A N D C L A S S I F I C AT I O N O F A RT I C L E S
I N S C I E N T I F I C L I T E R AT U R E
abstract
objective Once licensed, the benefit-risk profile of a vaccine requires
monitoring over its life cycle. For every assessment, prior published
evidence should be considered, but the large amount of available
literature hinders manual information extraction. We present automatic
methods for two basic tasks in the extraction of vaccine information
from scientific literature: recognition of vaccine descriptions (VDR) and
classification of vaccine articles (VAC).
materials and methods For VDR, we evaluated a method based
on the VaccO ontology of vaccine descriptions. For VAC, we compared
dictionary-based, ontology-based, and machine-learning methods to
assign MeSH vaccine headings to scientific articles. The approaches
were evaluated on a manually created reference corpus of vaccine de-
scriptions (VDR) and on MeSH vaccine headings from articles indexed
in PubMed (VAC).
results Our ontology-based method for VDR performed reasonably
well (F-score 0.69) considering the inter-annotator agreement on the
reference corpus (F-score 0.80). For VAC, a machine-learning method
performed best (F-score 0.76) but was outperformed by the ontology-
based method for infrequent MeSH vaccine headings.
discussion Vaccines are described considerably different than drugs,
requiring the development of vaccine-specific tools for VDR. Our
ontology-based approach could be improved by expanding the on-
tology and ameliorating the detection of vaccine-description contexts.
conclusion Using the VaccO ontology is a novel and promising
approach for VDR. Our reference corpus of vaccine descriptions is
the first of its kind and publicly available. For VAC, machine-learning
methods perform best for classifying common MeSH vaccine headings,
but for infrequent headings an ontology-based approach worked better.
Becker BFH, He HY, Sturkenboom MCJM, Kors JA. Identifying and Normalizing Vaccine
Descriptions in Scientific Literature (Submitted)
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E X T R A C T I O N O F C H E M I C A L - I N D U C E D D I S E A S E S
U S I N G P R I O R K N O W L E D G E A N D T E X T UA L
I N F O R M AT I O N
abstract
We describe our approach to the chemical-disease relation (CDR) task
in the BioCreative V challenge. The CDR task consists of two subtasks:
automatic disease named-entity recognition and normalization (DNER),
and extraction of chemical-induced diseasess (CIDs) from Medline ab-
stracts. For the DNER subtask, we used our concept recognition tool
Peregrine, in combination with several optimization steps. For the CID
subtask, our system, which we named RELigator, was trained on a
rich feature set, comprising features derived from a graph database
containing prior knowledge about chemicals and diseases, and lin-
guistic and statistical features derived from the abstracts in the CDR
training corpus. We describe the systems that were developed and
present evaluation results for both subtasks on the CDR test set. For
DNER, our Peregrine system reached an F-score of 0.757. For CID, the
system achieved an F-score of 0.526, which ranked second among 18
participating teams. Several post-challenge modifications of the systems
resulted in substantially improved F-scores (0.828 for DNER and 0.602
for CID). RELigator is available as a web service.136
5.1 introduction
The extraction of chemicals, diseases, and their relationships from un-
structured scientific publications is important for many areas of biomed-
ical research, such as pharmacovigilance and drug repositioning.82,137
Text-mining systems in combination with methods for literature-based
discovery and network analysis hold promise for automatically gener-
ating new hypotheses and fresh insights.138,139 The manual extraction
of these entities and relations, and their storage in structured databases
is cumbersome and expensive, and it is impossible for researchers or
curators to keep pace with the ever-swelling number of papers that
Pons E + Becker BFH, Akhondi SA, Afzal Z, van Mulligen EM, Kors JA. Extraction of
Chemical-Induced Diseases Using Prior Knowledge and Textual Information. Database
2016 (2016)
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are being published. Automatic extraction of chemical-disease relations
(CDRs) should solve these problems, but previous attempts have met
with limited success. One of the difficulties that has to be addressed is
the identification of relevant concepts, i.e., chemicals and diseases.140,141
Concept identification goes beyond concept recognition in that not only
the mention of a chemical or a disease has to be recognized, but that
in addition a unique identifier has to be assigned, which links the
concept to a source that contains further information about it.142 Also
the detection of relationships between the identified chemicals and
diseases remains a challenging task,143–145 partly because available an-
notated corpora to train and evaluate extraction algorithms are limited
in size.144,146
In BioCreative V, one of the challenge tasks is the automatic extrac-
tion of CDRs from biomedical literature.147 The CDR task comprises
two subtasks. The first subtask involves automatic disease named-entity
recognition and normalization (DNER) from a set of Medline docu-
ments, and can be considered as a first step in CDR extraction. The
second subtask consists of extracting chemical-induced diseases (CID)
and delivering the chemical-disease pairs per document.
Our team participated in both CDR subtasks. For the DNER subtask,
we used our concept recognition tool Peregrine, in combination with
several optimization steps.148 For the CID subtask, we applied the op-
timized Peregrine system for disease concept recognition; for chemical
concept recognition, we used tmChem, a chemical concept recognizer
that was provided by the challenge organizers.149 A relation extraction
module was trained on a rich feature set, including features derived
from a graph database containing prior knowledge about chemicals
and diseases, and linguistic and statistical features derived from the
training corpus documents.
In the following, we describe the systems that we developed for the
BioCreative challenge, as well as several post-challenge improvements,
and present evaluation results for both subtasks on the CDR training
and test sets.
5.2 methods
Figure 5.1 shows the different steps in our workflow for CDR extraction
from biomedical abstracts. The data, methods for entity recognition and
normalization, and relation extraction methods are described below.
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Figure 5.1: Workflow for CDR extraction. The chemical and disease entities in a
Medline abstract are recognized and mapped to their corresponding
MeSH identifiers by tmChem (for chemicals) and Peregrine (for dis-
eases). For each possible combination of chemicals and diseases that
are found in the document, features are generated based on prior
knowledge from a knowledge platform, and based on statistical
and linguistic information from the document. The features are fed
to an SVM classifier to detect CIDs.
Table 5.1: Characteristics of the CDR corpus
Data Training Devel. Test Total
Abstracts 500 500 500 1,500
Chemical mentions 5,203 5,347 5,385 15,935
Unique chemical identifiers 1,467 1,507 1,435 4,409
Disease mentions 4,182 4,244 4,424 12,850
Unique disease identifiers 1,965 1,865 1,988 5,718
CDRs 1,038 1,012 1,066 3,116
5.2.1 Data
The CDR task data consist of a training, a development and a test set,
each containing 500 Medline abstracts. Chemicals and diseases in the
abstracts were manually annotated in the form of text offset, text span,
and Medical Subject Headings (MeSH) identifier.147 Chemical-disease
interactions were annotated at the document level as MeSH-identifier
pairs, but only if a mechanistic relationship between a chemical and a
disease was explicitly mentioned in the abstract.150 Therapeutic rela-
tionships between chemicals and diseases were not annotated. Table 5.1
shows the number of annotated (unique) identifiers of chemicals and
diseases, and the number of annotated relationships.
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5.2.2 Entity Recognition and Normalization
Chemical concept recognition was carried out using the tmChem chem-
ical recognizer system.149 The tmChem system was one of the best
performing systems in the previous BioCreative IV chemical-named
entity recognition (CHEMDNER) challenge.45 It includes a dictionary
look-up to map recognized chemicals to MeSH identifiers. tmChem is
an ensemble system that combines two systems based on conditional
random fields (CRFs), of which we only used the one that performed
best in the CHEMDNER challenge. We trained this system on the 1,000
documents in the CDR training and development sets.
For the recognition and normalization of diseases, we employed our
dictionary-based concept recognition system Peregrine.148 Peregrine
employs a user-supplied dictionary and splits the terms in the diction-
ary into sequences of tokens. When such a sequence of tokens is found
in a document, the term and the concept associated with that term, is
recognized in the document. Peregrine removes stopwords (we used
the PubMed stopword list151) and tries to match the longest possible
text phrase to a concept. It uses the Lexical Variant Generator tool
(LVG) to reduce tokens to their stems before matching.152
We constructed a dictionary with concepts and corresponding terms
taken from four biomedical vocabularies, as contained in the Unified
Medical Language System (UMLS) 2015AA edition.153 These are: MeSH;
Medical Dictionary for Regulatory Activities (MedDRA); SNOMED
Clinical Terms (SCT), and International Classification of Diseases Clin-
ical Modifications version 10 (ICD-10 CM). The MetamorphoSys tool153
was used to only include concepts that belong to the semantic group
Disorders,154 and to discard terms that are flagged as suppressible in
the UMLS.
After a document was processed with Peregrine, several post-pro-
cessing steps were executed. We extracted all abbreviations and their
corresponding long forms,155 and made sure that any combination of
abbreviation and long form was tagged with the same concept. Adja-
cent term spans that were identified as the same concept were merged.
For our challenge submission on the test set, we filtered out terms that
Peregrine had tagged erroneously in the training and development
data (false-positive terms).
After the challenge, we refined this approach by only removing false-
positive terms if the ratio of true-positive to false-positive terms was
lower than 0.3. This threshold was heuristically set based on the train-
ing data to prevent that an occasional false-positive detection would
cause the removal of terms that were generally correctly recognized.
Moreover, we performed a term-frequency analysis by indexing a ran-
dom set of one million Medline abstracts and manually checking the
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2,000 top-ranking terms found by Peregrine. Erroneously recognized
terms were also removed. Finally, we added all terms that Peregrine
had missed in the training set (false-negative terms) to the dictionary.
The UMLS identifiers of the concepts that resulted from the indexing
and post-processing steps were mapped to MeSH identifiers with the
IntraMap tool.153 IntraMap contains a precompiled mapping table that
links each UMLS concept to the semantically closest MeSH header.
5.2.3 Relation Extraction
We formulated the relation extraction task as a binary decision problem:
for each possible pair of chemicals and diseases found in a document,
determine whether there is a relationship. To train the relation extrac-
tion algorithm, we constructed training instances based on the perfect
(gold-standard) entity annotations of the training data. Of the 10,693
possible pairs of annotated chemicals and diseases, 2,050 were labelled
as positive instances because the pair had been annotated as a relation-
ship by the reference. The other 8,643 pairs were labelled as negative
instances. Co-occurrence pairs were allowed to cross the title-abstract
border. For each instance, three sets of features were generated, based
on prior knowledge and on statistical and linguistic information from
the document.
Prior knowledge features
To generate features based on existing, prior knowledge, we used
a graph database, the Euretos Knowledge Platform.156 The Euretos
Knowledge Platform is a commercial system and not freely available
but life-science researchers can request free browsing access. We have
obtained an academic license to use a local installation of the sys-
tem. The graph database contains entities and relations from (curated)
structured databases, such as UniProt, the Comparative Toxicogen-
omics Database and UMLS, and from scientific abstracts (semantic
Medline).157 Each connection between entities can have a set of named
relations or predicates. Attached to each predicate is provenance in-
formation, including the different sources in which the relation was
found and, per source, the number of records or abstracts with the
relation. Euretos provides an application programming interface that
was used to query the database for paths between two given entities. A
path can be direct (i.e., the entities have a direct, one-directional (causal)
or two-directional (non-causal), relationship) or indirect (the entities
are connected through one intermediate entity; if the two relationships
involved are one-directional, one relationship should point towards
the intermediate entity and the other should point away from it). For
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each path, a confidence score based on provenance information was
computed that indicates how strongly the entities are related. If two en-
tities were connected through both direct and indirect paths, the latter
were ignored. If there were multiple paths of the same length, the total
score and total provenance count were taken as the maximum of the
path scores and path provenance counts, respectively. The provenance
count of an indirect path was taken as the minimum of the proven-
ance counts of the two predicates involved. We determined for each
chemical-disease pair the path type (direct, indirect or no path), the
confidence score, the number of paths, the set of predicates involved
and the provenance count.
Statistical features
The statistical feature set contained, for each chemical-disease pair at
the document level, the number of mentions of the chemical and of the
disease and number of possible chemical-disease pairs in the document
(i.e., number of chemical mentions times number of disease mentions).
The ratios of these numbers to the numbers of all chemical mentions,
all disease mentions and all possible chemical-disease pairs in the
document were also taken as features. Additional features captured
the minimal sentence and word distance between the mentions of
the chemical and the disease. Binary features indicated whether the
chemical, the disease or both were mentioned in the document title.
The MeSH identifiers of the chemical and disease were included as
nominal features.
Linguistic features
We used the Stanford CoreNLP parser in version 3.4.1 with the English
PCFG parsing module to generate dependency trees of the sentences
of each document, and determined governing verbs of chemicals and
diseases, and relating words of chemical-disease pairs (figure 5.2). The
governing verb of a word was defined as the first verb in the parse tree
that was encountered when traversing the tree from the word towards
the root. The relating word of a chemical-disease pair was defined as
the first word in the parse tree that the chemical and disease had in
common. If the chemical and disease mentions appeared in different
sentences, the relating word was undefined.
Two sets of linguistic features were used. For the first set, only one
pair of chemical and disease mentions in the document was considered.
The pair was selected on the basis of the following heuristics. A pair
with the chemical and disease mentions in the same sentence had
precedence over a pair with mentions in different sentences, and a pair
where no other chemical-disease pair could be found lower in the parse
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demonstrated
However acetaminophen has been produce
symptoms
anaphylaxis
to
hypotension
individuals
sensitive
wr, vc
vd
Figure 5.2: Example dependency parse tree for the sentence ‘However, acet-
aminophen has been demonstrated to produce symptoms of ana-
phylaxis, including hypotension, in sensitive individuals.’. The gov-
erning verb vd of the disease is ‘produce’; the governing verb vc of
the chemical is ‘demonstrated’, which coincides with the relating
word wr.
tree had precedence over a pair for which this was not true. If there were
only pairs with mentions in different sentences, the last pair with the
chemical mention before the disease mention was selected. If no such
pair existed, the first chemical and disease mentions in the document
was selected. The following features were derived: governing verb of
the chemical and of the disease, relating word, and governing verb of
the relating word. Note that if the chemical and the disease occurred in
different sentences, the governing verbs were taken from different parse
trees and the relating word and its governing verb were undefined.
Further features indicated whether the chemical was mentioned before
the disease, and whether another chemical-disease pair could be found
lower in the parse tree. After the challenge, we added four features
that signified whether the relating word and the governing verb of
the chemical, of the disease, and of the relating word, were negated.
Negation was assessed by the presence of negation modifiers in the
parse tree. Three more post-challenge features indicated whether the
chemical was the same as the relating word, whether the governing
verb of the disease was the same as the relating word, and whether
both governing verbs were the same as the relating word.
For the second set of linguistic features, we aggregated information
about the governing verbs and relating words from all possible pairs of
chemical and disease mentions in the documents. This set contained one
numeric feature for each governing verb or relating word encountered
in the training set, indicating how many times that word was found as
a governing verb or relation word for the chemical-disease pairs in the
document.
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Machine learning
Various machine-learning algorithms were explored, utilizing Weka
machine learning libraries.158 Performance was estimated by 10-fold
cross-validation.
In a preliminary analysis in which we compared various classification
algorithms, support vector machines (SVMs) proved to have superior
performance. Therefore, we continued to optimize parameters for the
SVM classification model. We used C-support vector classification with
radial basis function kernel type, initially with default settings for cost
(1.0) and gamma (0.0).
All numeric features were normalized to scale between zero and one.
Because of the class imbalance the cost matrix of the SVM was set to 5:1,
giving extra weight to the minority class. Utilizing the best performing
feature set, we tuned the cost and gamma parameters by performing a
grid search, again applying 10-fold cross-validation. During the grid
search, we used a fixed decision threshold of 0.5 for the SVM. We
subsequently varied the decision threshold to optimize the F-score of
the SVM.
Evaluation
For each document, the disease concepts and the disease-chemical
relationships found by our systems were compared with the gold-
standard annotations, resulting in true-positive, false-positive and false-
negative detections. Micro-averaged precision, recall and F-score were
then computed over the whole document set. We implemented our
final challenge systems as web services, which the CDR task organizers
utilized for online system evaluation on the test set.
5.3 results
5.3.1 DNER task
Table 5.2 shows the performance of the Peregrine challenge system
and the system with post-challenge modifications on the DNER test
set. The challenge system obtained an F-score of 0.757. The modified
system performed considerably better achieving an F-score of 0.828,
well above the average F-score (0.760) of the 16 teams participating in
the DNER task.147
To get insight in the cause of the remaining errors of the modified
Peregrine system, we randomly selected and analysed 50 false-positive
and 50 false-negative detections. Table 5.3 shows that almost half of
the false-positives were due to incorrectly recognized terms, e.g., in
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Table 5.2: Performance of the Peregrine challenge and post-challenge systems
for disease normalization on the test set
System Recall Precision F-score
Peregrine, challenge 0.772 0.737 0.757
Peregrine, post challenge 0.839 0.818 0.828
Table 5.3: Error analysis of 50 false-positive (FP) and 50 false-negative (FN)
errors of the post-challenge Peregrine system
Error type FP FN
Term mapped to incorrect MeSH identifier 8 6
Term incorrectly on exclusion list - 5
Term partially recognized 13 15
Term incorrectly recognized 23 -
Term not recognized - 20
Annotation error 6 4
the form of an erroneous synonym (‘patch’ for ‘plaque’) or a term
that is no disease (‘glucose tolerance curve’). The largest group of
false-negatives resulted from missing synonyms in the terminology.
Interestingly, many of these synonyms were present in other vocab-
ularies in the UMLS than the ones that we selected for building our
terminology. A smaller number of terms were correctly recognized but
then mapped to the wrong MeSH identifier, or were excluded because
their true-/false-positive ratio was below the threshold of 0.3. Partial re-
cognition of terms, e.g., ‘carcinoma’ in ‘cervical carcinoma’ or ‘ethanol
abuse’ in ‘cocaine and ethanol abuse’, resulted in considerable numbers
of false-positives as well as false-negatives. Finally, we encountered a
number of gold-standard annotation errors. For example, in the term
‘ST depression’, an electrocardiographic concept, ‘depression’ had been
annotated as a psychological disorder. As another example, a mention
of the term ‘death’ had not been annotated, whereas the annotation
guidelines explicitly state that this term should be annotated.
5.3.2 CID Task
Table 5.4 shows the results of different relation extraction systems on the
CDR training and development data, using the gold-standard chemical
and disease annotations to generate all possible chemical-disease pairs.
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Table 5.4: Performance of different relation extraction systems on the CDR
training and development data, given perfect entity annotations
System – features Threshold* Recall Prec. F-score
Sentence co-occurrence n/a 0.725 0.313 0.437
Prior knowledge n/a 0.664 0.405 0.503
SVM – all challenge 0.30 0.840 0.693 0.760
SVM – all post-challenge 0.34 0.854 0.753 0.801
– without prior knowledge 0.33 0.765 0.695 0.728
– without statistical 0.39 0.775 0.683 0.726
– without linguistic 0.38 0.842 0.701 0.765
* Probability threshold for the SVM to decide whether there is a relationship.
A baseline system based on sentence co-occurrence of entities gave
an F-score of 0.437 with a recall of 0.725, indicating that more than a
quarter of the relations spanned more than one sentence. The appli-
cation of prior knowledge, assuming that a relation was present if a
chemical and a disease were directly connected in the Euretos Know-
ledge Platform by a non-treatment predicate, resulted in an F-score
of 0.503. When the SVM was trained with all the challenge features
(i.e., without the negation and word correspondence features that we
defined post-challenge), we achieved an F-score of 0.760. Including
all our features further improved the F-score to 0.801. To assess the
performance contribution of the different features sets, we retrained
the system after removing each feature set in turn. Removal of the
prior knowledge features or the statistical features resulted in a similar
drop of performance (F-scores of 0.728 and 0.726, respectively). Leaving
out the linguistic features reduced performance to some lesser extent
(F-score 0.765).
Table 5.5 shows the performance results of the SVM classifier, using
tmChem and Peregrine for entity normalization, on the CDR test set.
For the CDR challenge, we submitted three runs using the SVM trained
on the challenge features, in combination with tmChem and the Per-
egrine challenge system: one run used the decision threshold of 0.30
that resulted from our cross-validation experiments, the other two runs
used thresholds of 0.20 and 0.40. The best F-score was 0.569, which was
achieved for a threshold of 0.2. This result is higher than the F-score of
0.526 reported in the CDR challenge proceedings.147,159 The reason is
that the server showed occasional race-conditions during the challenge,
which we only discovered and fixed after the challenge. Our system,
which we named RELigator, ranked second among the systems of 18
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participating teams in the CDR task (the best team achieved an F-score
of 0.570).147 Use of the improved, post-challenge Peregrine system only
slightly improved performance (F-score 0.557 vs. 0.563 at a threshold
of 0.3). However, the system trained with the additional post-challenge
features yielded a considerably improved F-score of 0.602. For com-
parison, we also evaluated this SVM using the gold-standard entity
annotations. This resulted in an F-score of 0.702.
5.4 discussion
We described our Peregrine-based system for disease normalization,
and the RELigator system for CDR extraction. RELigator achieved an
F-score of 0.526 for the CID challenge, which ranked second among
18 participating teams. Several post-challenge modifications of the
systems resulted in a substantially improved F-score of 0.602 for CID,
currently outperforming the best challenge submission. Evaluation of
CID extraction using gold-standard entity annotations illustrates that
the quality of entity recognition is still an important limitation.
Regarding the CDR extraction, our results indicate that knowledge-
based features, statistical features and linguistic features each contrib-
ute to the final system performance, and thus contain at least partly
complementary information.
Our original Peregrine system (F-score 0.757) was outperformed
in the challenge by CRF-based disease recognition systems, with an
F-score of 0.865 for the best performing system. The post-challenge
modifications of Peregrine resulted in a substantial performance im-
provement (F-score 0.828). This result compares favourably with the
F-score of 0.698 that we obtained in a previous study in which we
also used Peregrine for disease concept recognition in a set of Med-
line abstracts.140 The lower performance in that study may partly be
explained by the more demanding task to recognize disease concepts
from any vocabulary in the UMLS, not just from MeSH like in this
study.
Our error analysis revealed that most disease recognition errors were
terminology-related. Inclusion of other vocabularies from the UMLS
to increase the coverage of synonyms in combination with filtering
on semantic types and manual term curation, may further improve
Peregrine’s performance.
Remarkably, the gain in Peregrine performance before and after the
challenge hardly increased the performance of the relation extraction
pipeline (F-score rose from 0.557 to 0.563, using the challenge feature
set and a decision threshold of 0.3 for the SVM classifier). There may
be several reasons for this. First, relation extraction performance is
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dependent on the performance of both the disease concept recognition
and the chemical concept recognition. Improved disease recognition
alone will therefore only be partially reflected in improved relation
extraction. Second, disease recognition performance is based on the
annotations of all unique disease mentions in the abstracts, whereas
relation-extraction performance is based on disease annotations at the
document level. The test contains 1,988 gold-standard annotations of
unique disease mentions and 865 gold-standard disease annotations
that are part of CDRs. Again, improved performance of the disease
recognition step is likely to be only partially reflected in improved
relation extraction.
Despite the noisy entity data for instance generation, we still per-
formed second in the challenge for CID extraction. Because the per-
formance of relation extraction is not evaluated independently of entity
recognition, it is hard to put the CID results into perspective. The task,
in-part inspired by the needs of CTD curators, did not distinguish
between DNER and CID performance, while this seems essential to
bring this task forward.
The inter-annotator agreement (IAA) for the CID corpus is not known.
Wiegers et al. reported a surrogate IAA score of 77% for annotation
of chemical-gene interactions.160 This IAA averages agreement of each
annotator against a gold standard, created by disagreement resolution,
which presumably overestimates the true IAA. Our system has a micro-
averaged F-score of 70% using gold-standard annotations, and may
come within reach of the IAA. However, formal assessment of CID IAA
needs to be performed.
Several improvements of the final model can be envisaged. The scope
of syntactically connected chemical–disease pairs could be expanded
through anaphora resolution. Governing and relating words could
be encoded as word embeddings instead of nominal values, giving
them a more compact and semantically rich representation. Simple
token features in a window around chemical and disease could provide
further context. Finally, the CDR annotations that we used to train our
models were provided at the document level. We did not attempt to
annotate the relation mentions in the document texts, which might
have yielded stronger features.
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abstract
background Assessment of drug and vaccine effects by combining
information from different healthcare databases in the European Union
requires extensive efforts in the harmonization of codes as different
vocabularies are being used across countries. In this chapter, we present
a web application called CodeMapper, which assists in the mapping of
case definitions to codes from different vocabularies, while keeping a
transparent record of the complete mapping process.
methods CodeMapper builds upon coding vocabularies contained in
the Metathesaurus of the Unified Medical Language System (UMLS).
The mapping approach consists of three phases. First, medical concepts
are automatically identified in a free-text case definition. Then, the user
revises the set of medical concepts by adding or removing concepts,
or expanding them to related concepts that are more general or more
specific. Finally, the selected concepts are projected to codes from the
targeted coding vocabularies. We evaluated the application by compar-
ing codes that were automatically generated from case definitions by
applying CodeMapper’s concept identification and successive concept
expansion steps using the revision operations, with reference codes
that were manually created in a previous study.
results Automatic concept identification alone had a sensitivity of
0.246 and positive predictive value (PPV) of 0.420 for reproducing the
reference codes. Three successive steps of concept expansion increased
sensitivity to 0.953 and PPV to 0.616.
conclusions Automatic concept identification in the case definition
alone was insufficient to reproduce the reference codes, but CodeMap-
per’s operations for concept expansion provide an effective, efficient
and transparent way for reproducing the reference codes.
Becker BFH, Avillach P, Romio S, Mulligen EM, Weibel D, Sturkenboom MCJM, Kors
JA. CodeMapper: Semiautomatic Coding of Case Definitions. A Contribution from the
ADVANCE Project. Pharmacoepidemiology and drug safety 26 (2017)
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6.1 introduction
In order to increase the scale of pharmacoepidemiological studies,
information from multiple electronic health record (EHR) databases
should be combined in a distributed, collaborative fashion.46 However,
EHR databases use different coding vocabularies to record medical
information,162,163 such as the International Classification of Diseases
Clinical Modifications version 9 (ICD-9 CM)164 and version 10,165 the
International Classification of Primary Care version 2 (ICPC-2),166
Read codes version 2 (Read-2)167 and Read Clinical Terms version 3
(CTv3).168 In multi-database studies, the extraction of an event typically
requires several steps to achieve consistency between databases. A case
definition that describes the event in the study protocol is translated
into an operational definition, which is then mapped for each vocab-
ulary into a set of codes that represents the event. The code sets are
combined into queries for case identification and harmonized between
databases by comparison with benchmarks from the literature and by
feedback from the database custodians.
The creation of code sets for each vocabulary from the textual case
definitions has been largely a manual process. Given the number and
complexity of the targeted vocabularies, the mapping and harmoniza-
tion process can pose an important bottleneck to the rapid implement-
ation of collaborative epidemiological studies.49,50 Furthermore, the
rationale for including or excluding individual codes is not consist-
ently documented, which hampers the possible reuse of code sets and
queries in subsequent studies.
A previous attempt to accelerate the creation of code sets from
multiple vocabularies was made in the EU-ADR project.49,51,169 Med-
ical concepts like diseases, symptoms, laboratory procedures, or tests
were automatically identified in a case definition using the MetaMap
program.170 Code sets representing the concepts in the targeted vocab-
ularies were then generated using the Unified Medical Language Sys-
tem (UMLS),52 a biomedical terminology system that integrates many
vocabularies including coding vocabularies commonly used in EHR
databases. Whereas the identification of concepts and their projection
to codes was automatic, the overall workflow was not integrated or
recorded to facilitate the later reuse of the mapping. The approach
was applied also in other European projects like GRIP,171 VAESCO,172
and EMIF.173 Similar collaborative studies in the American, Asian
and Pacific regions deal with less heterogeneous medical vocabular-
ies (Mini-sentinel,174 PRISM,175 VSD,176 and AsPEN177). Alternatively
to adapting the event identification algorithm to the different data-
bases, these databases can be mapped to a standardized coding system.
A single event identification algorithm can then be used in different
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databases. This approach is being pursued by OMOP and the OHDSI
collaboration.178,179
We present a web application called CodeMapper, which has been
developed in the ADVANCE project (Accelerated Development of
VAccine beNefit-risk Collaboration in Europe).180 It is based on the
EU-ADR approach and assists in mapping case definitions to code sets
from different vocabularies while keeping a record of the complete
mapping process. We evaluate the application by comparing code sets
that were automatically generated by CodeMapper with reference code
sets that were manually created in a previous epidemiological study.
6.2 methods
CodeMapper’s mapping approach consists of three phases (figure 6.1,
top). First, medical concepts are automatically identified from a free-
text case definition. The user can then revise the set of medical concepts
by adding or removing concepts, or expanding a concept to more
general or more specific concepts. For example, the concept Coughing
can be expanded to more general concepts such as Respiratory disorders
and Abnormal breathing. Expanding it to concepts that are more specific
results in subtypes of coughing such as Paroxysmal cough and Evening
cough. Finally, each concept is represented by (possibly several) codes
in the targeted vocabularies, and the projection of the concepts to
codes forms the result of the mapping process. In this section, we will
describe the mapping approach, the CodeMapper application, and an
evaluation of the approach.
6.2.1 Mapping approach
CodeMapper builds upon information from the Metathesaurus of the
UMLS. The Metathesaurus is a compendium of many medical vocabu-
laries, which have been integrated by assigning equivalent codes and
terms from different source vocabularies to the same concepts. Each
concept in the UMLS is identified by a CUI. For example, the concept
Coughing (CUI: C0010200) is among others associated with the codes
786.2 (from ICD-9 CM), R05 (from ICD-10 CM) and XC07I (from CTv3).
The Metathesaurus contains more than one million concepts connected
to codes from 201 vocabularies. Each concept is assigned to one or
more of 127 semantic types, which define broad conceptual categories
like Disease or syndrome, Finding, or Substance. To provide even broader
structure, semantic types are combined into 15 semantic groups.154 We
used version 2016AA of the UMLS in this evaluation.
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The automatic concept identification of CodeMapper is based on
lexical information from the Metathesaurus (figure 6.1, left). The lexical
information of a concept consists of terms that can be used in free-text
to refer to that concept. We compiled a dictionary for the concepts in
the semantic groups Anatomy, Chemicals & drugs, Disorders, Genes &
molecular Sequences, Living beings, Phenomena, Physiology, and Procedures
of non-suppressible, English terms from the following vocabularies:
Medical Subject Headings (MeSH),30 Medical Dictionary for Regulatory
Activities (MedDRA),118 SNOMED Clinical Terms (SCT),119 ICD-9 CM,
ICD-10 CM, ICPC-2, and CTv3. Our text-indexing engine Peregrine uses
this dictionary to identify medical concepts in the case definition.148
CodeMapper provides two operations to improve the sensitivity of
the mapping by expanding a concept to more general or more spe-
cific concepts, based on the hierarchical relationships defined in the
Metathesaurus (figure 6.1, centre). Hierarchical relationships connect
concepts that are more general or more specific in meaning. For ex-
ample, the concept for Coughing is connected to the more general
concept Respiratory Disorders, and to the more specific concept Par-
oxysmal cough. To expand a concept in CodeMapper, all concepts that
have a more general (or more specific relationship) with it are identified
and displayed in the application for selection by the user. Hierarchical
relationships in the Metathesaurus are inherited from the source vocab-
ularies or defined in the Metathesaurus.181 Both types of hierarchical
relationships are taken into account for concept expansion.
The projection of concepts to code sets from the targeted vocabularies
follows the assignment of codes to concepts in the Metathesaurus
(figure 6.1, right).
6.2.2 Application
The CodeMapper application is implemented as an open-source web
application and freely available for non-commercial use.182,183 Code-
Mapper has three screens. On the first screen, the user enters a clinical
case definition of an event as free-text. Medical concepts are automat-
ically identified in the text and highlighted inline. By default, only
concepts that belong to the semantic group of Disorders are preselected
for further processing in the application, but the user can select and
deselect any identified concept depending on their relevance for the
described event.
The second screen displays the mapping as a table with one row for
each medical concept, and one column for each targeted vocabulary
(figure 6.2 a). Each cell contains the names of the codes that are used
to represent the medical concept of the row in the targeted vocabulary
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of the column. The codes are displayed when the names are hovered
over with the mouse. Several user operations are available for revising
the mapping. The user can remove concepts from the mapping, query
for and add new concepts, or automatically retrieve more general
and more specific concepts. The retrieved concepts are shown in a
list and can be selected by the user for inclusion in the mapping. The
user can also add or remove vocabularies that should be targeted
by the mapping (figure 6.2 b). After every operation, the codes are
automatically updated and displayed in the table.
The third screen shows a list of all operations that have been made,
for later traceability of the mapping process. When the user saves the
mapping, he has to provide a summary of the modifications, which
is incorporated into the mapping history. After saving, the mapping
and history list are available to other users of the application. Com-
ments can be attached to concepts to capture the discussion about the
mapping. Concepts can be categorized by tags, which are inherited by
the projected codes. Finally, the user can download the mapping as a
spreadsheet file, for example to incorporate the codes into extraction
queries. The spreadsheet file comprises the original free-text case defini-
tion, the concepts of the mapping, the codes for the targeted vocabulary,
and the full history of the mapping process.
6.2.3 Evaluation
We evaluated the effectiveness of CodeMapper’s approach for creating
realistic code sets for a number of case definitions, by comparing code
sets that were generated with CodeMapper with manually created
reference code sets. We used case definitions and reference code sets
from the FP-7-funded SAFEGUARD project, which was conducted
in nine EHR databases in the EU and USA. (The full study protocol
including the case definitions is available in the EU-PAS registry.184)
This project was selected for the variety of mapped events and the
range of targeted vocabularies. The manual mapping process consisted
of deriving operational definition from the textual case definition,
choosing codes from the targeted vocabularies without the use of the
Metathesaurus, and refining the code set based on feedback from
database custodians. The reference mappings also contained exclusion
codes, which were not considered in the evaluation because they were
generally not derived from the case definitions.
SAFEGUARD studied nine events: acute pancreatitis, bladder cancer,
haemorrhagic stroke, heart failure, ischemic stroke, acute myocardial
infarction, pancreatic cancer, sudden cardiac death, and ventricular
arrhythmia. One event (sudden cardiac death) was excluded from the
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a)
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Figure 6.2: a) The second screen of the CodeMapper application shows the mapping as table
and provides operations to revise the concepts of a mapping. The cells show the
code names from the vocabulary stated in the column that correspond to the concept
of the row. Individual codes are shown when hovering the terms. The balloon
symbols in the last column indicate the number of comments attached to a concept.
b) Example of the operation for concept expansion: The list of concepts that are more
specific than Pertussis are displayed for the selection and insertion in the mapping.
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Table 6.1: Number of words in case definitions and number of codes in the
reference set. The numbers of exclusion codes are given in brackets.
Event Case definition Codes
(word count) ICD-9 ICD-10 ICPC-2a) READ-2
Acute pancreatitis 49 1 (0) 6 (0) 1 (0) 7 (0)
Bladder cancer 87 12 (0) 12 (0) 1 (3) 91 (0)
Hemorrhagic stroke 48 3 (2) 22 (2) 1 (2) 36 (0)
Ischemic stroke 53 10 (0) 11 (0) 2 (1) 20 (0)
Acute myocardial infarction 39 11 (1) 7 (0) 1 (6) - b)
Pancreatic cancer 19 8 (0) 9 (0) 1 (1) 109 (0)
Ventricular arrhythmia 234 5 (0) 5 (0) 1 (1) 27 (0)
Sum 529 50 (3) 72 (2) 8 (14) 290 (0)
Average 75.5 7.1 10.2 1.1 48.3
a) Additional text-based queries for IPCI database
b) Text-based query only for GePaRD database
evaluation because of several missing code sets, and another (heart
failure) because the case definition contained only a short symptomatic
description of the event, unrelated to the codes representing the event.
The events were mapped for nine EHR databases with four vocabu-
laries: Medicare, PHARMO, HSD and regional EHR databases from
Lombardy and Puglia (all these databases use ICD-9 CM), GePaRD
(ICD-10, German modifications), IPCI and BIFAP (both ICPC-2 and
keywords), and CPRD (Read-2). For ICD-9 CM we selected the code sets
for Medicare as the reference since it contained less database-specific
additions than the other code sets using ICD-9 CM. The codes for
GePaRD are contained by the ICD-10 and ICD-10 CM vocabularies in
the UMLS, so we combined the codes generated by CodeMapper for
these vocabularies. To generate codes for Read-2, a translation table
between Read-2 and CTv3 was integrated into CodeMapper, because
the Metathesaurus covers only CTv3 and not Read-2. (The mapping
table is available at the Health & Social Care Information Centre.)
Codes from the IPCI mapping were trimmed to three digits to adjust
for the database-specific codes in IPCI.
Overall, the reference code sets contained 529 codes (table 6.1). The
size of the reference code sets vary widely between vocabularies: on
average, the code sets for Read-2 contain 48.3 codes, whereas the code
sets for ICPC-2 contain 1.1 codes. This discrepancy is firstly due to
the differences of granularity of the vocabularies (Read-2 has 77,290
codes in the Metathesaurus, ICPC-2 only 1,397). Secondly, the queries
to the IPCI database (to which the ICPC-2 code sets were targeted) are
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(free text)
Baseline
Expansions step
CodeMapper
code sets
Reference
code sets
Concept
identification
Revision
CodeMapper operation (automatic)
Manual mapping (reference project)
Comparison for evaluation
CodeMapper results
Figure 6.3: Automatic evaluation of CodeMapper. Reference code sets were
created manually for each targeted vocabulary from the free-text
case definition of an event. The baseline mappings and expansion
steps were generated automatically from the same case definition
using the operations available in CodeMapper.
supported by keyword searches on the free-text portion of the IPCI
medical records and additional exclusion criteria.
Different code sets were generated fully automatically by CodeMap-
per for the events of the reference project based on the same case
definitions. The baseline code sets resulted from the concepts identified
in the case definition (figure 6.3). We then simulated the actions of an
‘informed user’ who seeks to improve the sensitivity of the mapping.
We assumed that this user would expand the concepts and, from all
possible concepts that are more general or more specific, would only
retain those that are relevant to the event. Based on the reference set
we were able to automatically simulate the ‘informed user’s’ actions.
The resultant set of concepts defined a new code set, which always
contained all codes from the preceding code set. We simulated four of
these expansion steps on successive concept sets.
For each target vocabulary and event, the generated code sets were
compared with the reference code sets. We determined the number of
true-positive codes (TP), false-positive codes (FP), and false-negative
codes (FN), and computed sensitivity as TP/(TP + FN) and positive
predictive value (PPV) as TP/(TP+ FP). We report for each vocabulary
the sensitivity and PPV averaged over all events in the reference set.
6.2.4 Error analysis
We then carried out an automatic error analysis of the false-positive
and false-negative codes after the third expansion step (figure 6.4). The
definitions of the error categories were based on the notion of sibling
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Reference
codes
Generated
codes
Codes in the
Metathesaurus
Selected conceptsConcept identifiers
False positives:
• without true-
positive sibling
• with true-
positive sibling
True positives
False negatives:
• not in UMLS/
CodeMapper
• no sibling
in reference
Figure 6.4: Categories of false negatives and false positives in the error analysis.
Two codes are siblings if they are associated with the same concept.
codes: two codes are siblings if they are linked to the same concept in
the Metathesaurus. For false negatives, we distinguished between codes
that are not contained in the Metathesaurus and codes whose siblings
are not in the reference sets. False positive codes were categorized as
having or not having a true-positive sibling code.
6.3 results
6.3.1 Baseline
The baseline mapping created by CodeMapper comprised 46 concepts
and had an average sensitivity of 0.246 for reproducing the reference
code sets (table 6.2). The average PPV of the baseline mapping was 0.420.
Without filtering by the semantic group of Disorders, the number of
concepts would increase from 46 to 77 without affecting the sensitivity
of the codes sets.
6.3.2 Concept expansion
The average sensitivity of the baseline mapping greatly improved in
the first expansion step, to 0.818. Sensitivity further increased in the
second (0.940) and third (0.953) expansion steps. All ICPC-2 codes
were produced after the first expansion step and all ICD-10 CM codes
were produced after the second step. The sensitivity increased incre-
mentally for Read-2 and ICD-9 CM. The average PPV improved after
one expansion step (0.633) and decreased slightly after two (0.621)
and three (0.616) expansion steps. The performance did not improve
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Table 6.2: Number of concepts and performance measures of the baseline map-
ping and after the expansion steps. Numbers per vocabularies are
macro-averages over all events.
Revision (concepts) ICD-9 ICD-10 ICPC-2 READ-2 Avg.
Baseline (46) Sens. 0.300 0.195 0.357 0.131 0.246
PPV 0.387 0.380 0.500 0.411 0.420
Step 1 (183) Sens. 0.858 0.848 1.000 0.568 0.818
PPV 0.483 0.558 0.762 0.729 0.633
Step 2 (297) Sens. 0.914 1.000 1.000 0.846 0.940
PPV 0.463 0.509 0.762 0.749 0.621
Step 3 (335) Sens. 0.929 1.000 1.000 0.882 0.953
PPV 0.462 0.498 0.762 0.742 0.616
further in a fourth expansion step. The sensitivity was lower after three
expansion steps when using only hierarchical relationships that were
either inherited from the source vocabularies (0.928) or defined in the
Metathesaurus (0.879).
6.3.3 Error analysis
False-positive codes were generated in all vocabularies after the third
expansion step (N=234, table 6.3). Most false-positive codes had true-
positive siblings (N=164; 70.1%). False-positive codes without true-
positive siblings (N=70; 29.9%) resulted from the initial concept identi-
fication step because the concept expansion steps that simulated the
informed user added only concepts with true-positive codes.
False-negative codes occurred only for the vocabularies Read-2 and
ICD-9 CM (table 6.4). Most false negative codes did not have any
siblings in the reference set (N=24; 68.6%), suggesting that these codes
were added to the reference set due to database specific needs. Other
false-negative Read-2 codes were not contained in the conversion table
from CTv3 to Read-2 codes, or the CTv3 codes corresponding with the
Read-2 codes were not in the Metathesaurus (N=11; 31.4%).
A mapping constructed to maximize sensitivity by selecting concepts
to generate all available codes from the reference sets had a sensitivity
of 0.991 and PPV of 0.733.
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Table 6.3: Number of false-positive codes after three expansion steps by vocab-
ulary and error category, and their percentage of all false-positive
codes.
Vocabulary FP category Count Percentage
ICD-9 CM With TP sibling 52 22.2
No TP sibling 22 9.4
ICD-10 With TP sibling 66 28.2
No TP sibling 30 12.8
ICPC-2 With TP sibling 3 1.3
No TP sibling 1 0.4
READ-2 With TP sibling 43 18.4
No TP sibling 17 7.3
Overall With TP sibling 164 70.1
No TP sibling 70 29.9
Table 6.4: Number of false-negative codes after three expansion steps by vocab-
ulary and error category, and their percentage of all false-negative
codes.
Vocabulary FN category Count Percentage
READ-2 No sibling in reference 19 54.3
Not in UMLS 11 31.4
ICD-9 CM No sibling in reference 5 14.3
Overall No sibling in reference 24 68.6
Not in UMLS 11 31.4
6.4 discussion
In this chapter, we presented CodeMapper, a web application that
assists in the mapping of textual case definitions to code sets from
multiple vocabularies, which is often a bottleneck in the implementation
of epidemiological multi-database studies. We showed the effectiveness
of CodeMapper’s approach by simulating an informed usage of the
application.
Creating a mapping only by the automatic identification of medical
concepts in the case definition was insufficient for reproducing the
reference code sets (sensitivity 0.246). The mapping process cannot be
replaced by a simple indexing step. However, the goal of CodeMapper
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is to support an informed user in creating such mappings, and Code-
Mapper’s operations for concept expansion provide an effective and
efficient way for this. The reference code sets were regenerated with a
sensitivity of 0.953 and PPV of 0.616 after only three expansion steps.
The reference codes for ICPC-2 were even completely regenerated after
the first expansion step and the reference codes for ICD-10 CM after
the second expansion step. The sensitivity always increased between
expansion steps because codes were always retained in subsequent
steps. The increase of sensitivity came at the costs of a slight decrease
in PPV, which is a consequence of the introduction of false-positive
codes that are siblings of newly added true-positive codes. The sensit-
ivity was lower for more granular vocabularies, where more expansion
steps were required.
The performance of the mapping that simulated maximal sensitivity
(0.991 with associated PPV of 0.733) forms an upper bound of Code-
Mapper’s performance for the presented evaluation. The imperfect
sensitivity is due to reference codes that are missing in the UMLS or in
the mapping between Read-2 and CTv3. The moderate PPV may be due
to inconsistencies in the reference code sets or in the Metathesaurus.
The reference code sets may be inconsistent between vocabularies for
two reasons. First, the inclusion of one code in the reference mapping
did not always imply the inclusion of all sibling codes in the targeted
vocabularies, which is reflected by the high percentage of false positives
that have true-positive siblings. Second, different code sets were created
for databases with the same vocabularies, which can be necessary to
compensate for characteristics of the databases. For example, when an
event is only available as inpatient diagnosis in one database, a drug
that is usually prescribed in case of the event in outpatient setting can
be included in the query as a proxy. Such database-specific additions
also explain some false-negative codes without siblings in the reference
set. Inconsistencies in the Metathesaurus such as missing identification
of equivalent codes and incomplete coverage of vocabularies have been
discussed before.185–188
The SAFEGUARD reference set contained only codes for diagnoses
but no codes for laboratory, imaging, or ECG results. CodeMapper’s
operations for concept expansion would not be suitable for generating
such codes for diagnostic tests because the corresponding concepts
are not hierarchically related to the concepts for the diagnoses given
in the case definition. However, these result codes can be generated
using CodeMapper’s approach if the concepts for diagnostic tests are
mentioned in the case definition.
When exclusion criteria are indicated in the case definition, Code-
Mapper’s approach can be applied to map them to codes, but they must
then manually be tagged for exclusion to inform the data extraction
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process. Automatic negation extraction could be used to automate the
identification of exclusion criteria in the case definition.189
The use of the Metathesaurus in CodeMapper’s approach brings
practical limitations with it. Differences in granularity between vocabu-
laries can affect the consistency of the generated code sets. This problem
could be identified by incorporating information about code usage in
EHR databases into CodeMapper. Vocabularies that are not part of the
UMLS can only be targeted with CodeMapper by integrating additional
mapping tables. And database-specific code sets cannot be maintained
easily because code sets are generated per vocabulary.
CodeMapper has been applied to the mapping of 45 events in the
ADVANCE project so far. The automatic concept identification and
revision operations allowed a quick drafting and interactive exploration
of the code sets, without requiring extensive knowledge of each targeted
vocabulary. Feedback from medical experts and database custodians,
and harmonization between databases were crucial to identify missing
codes and concepts, and was collected in CodeMapper for subsequent
revision of the mappings. Together with the detailed history of all steps
that resulted in the mapping, CodeMapper facilitated an integrated
and transparent management of the overall mapping process.
In conclusion, the CodeMapper web application constitutes a single
entry point for the different phases of the terminology mapping pro-
cess for multi-database studies. The expansion operations provide a
more efficient and systematic way to add relevant related codes to the
mapping than browsing the source vocabularies. The integration of the
mapping process into a single application, and the recording of user
operations make the mapping process traceable, and the mappings
more suitable for reuse in subsequent studies.
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A L I G N M E N T O F VA C C I N E C O D E S U S I N G T H E
VA C C O O N T O L O G Y O F VA C C I N E D E S C R I P T I O N S
abstract
background Vaccine information is represented in European elec-
tronic health record (EHR) databases using various clinical and database-
specific coding systems and drug vocabularies. The lack of harmon-
ization constitutes a challenge in reusing EHR data in collaborative
benefit-risk studies about vaccines.
methods We designed an ontology of properties commonly used
in vaccine descriptions, VaccO, with a dictionary for the analysis of
multilingual vaccine descriptions. Based on the VaccO ontology, we
implemented different algorithms for the alignment of vaccine coding
systems, i.e., the identification of corresponding codes from different
coding systems. The algorithms were evaluated by comparing their res-
ults with manually created alignments in two reference sets including
clinical and database-specific coding systems with multilingual code
descriptors.
results The best-performing algorithm represented vaccine descrip-
tions as logical statements about entities in VaccO and used an ontology
reasoner to identify common properties between corresponding vac-
cine codes. The evaluation demonstrated excellent performance of the
approach (F-scores 0.91 and 0.96).
conclusion The VaccO ontology allows the identification, represent-
ation, and comparison of heterogeneous descriptions of vaccine and
vaccine groups. The automatic alignment of vaccine coding systems
accelerates the readiness of EHR databases in collaborative vaccine
studies.
availability The VaccO ontology and three web applications im-
plementing the analysis and alignment of vaccine codes are publicly
available.
Becker BFH, Kors JA, Mulligen EM, Sturkenboom MCJM. Alignment of Vaccine Codes
Using the VaccO Ontology of Vaccine Properties (Submitted)
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Post-marketing management and decision-making about vaccines builds
on the early detection of safety concerns and changes in public sen-
timent, the accurate access to established evidence, and the ability
to promptly quantify effects and verify hypotheses about the vaccine
benefits and risks (B/R). A variety of resources provide relevant in-
formation but they use different representations, which makes rapid
evidence generation and extraction challenging. This thesis presented
automatic methods for interpreting heterogeneously represented vac-
cine information (figure 8.1). Part I used automatic methods for the
first step in vaccine semantics, the recognition of information, whereas
the other steps were accomplished manually. Parts II and III developed
and evaluated automatic methods and resources for the recognition,
representation, and reasoning about vaccine-related information.
Chapter 2 was motivated by the question whether public social media
capture information that is relevant for the post-marketing management
of vaccines. The study provided negative evidence regarding the use
of social media for monitoring vaccine safety, but chapter 3 suggested
that changes in public attention and sentiment about vaccines and
vaccination programmes could be monitored in public social media.
Part II introduced methods that underlie the automatic extraction of
established evidence about vaccines from scientific literature. Chapter 4
addressed the recognition of vaccine descriptions and the classification
of articles by vaccines, two basic tasks in extracting vaccine-related
information. Our automatic method to recognize vaccine descriptions
based on the VaccO ontology performed reasonably well in comparison
with the inter-annotator agreement in a manually created reference
corpus of vaccine descriptions. A convolutional neural network (CNN)
performed best for categorizing vaccine literature but required substan-
tial training material for creating a well-performing classifier, which
may not be available for novel or less-studied vaccines. Chapter 5
presented a model for the automatic extraction of causal relations
between chemicals and diseases from scientific literature.
Part III contrasted two automatic approaches to harmonizing extrac-
tion queries for vaccines and outcomes from electronic health record
(EHR) databases that use different medical coding systems, which
is often a bottleneck in the implementation of collaborative observa-
tional studies. Chapter 6 introduced the web application CodeMapper
that implements a semi-automatic approach to mapping textual case
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definitions to database-specific extraction codes. CodeMapper was eval-
uated by simulating an informed usage, which showed the efficacy
of its user operations. Chapter 7 presented an approach for solving
heterogeneous representation of vaccine information in EHR databases
by automatically creating alignments between database coding sys-
tems. The algorithm for code alignment is based on the newly created
ontology of vaccine descriptions, VaccO. The automatically generated
alignments between vaccine coding systems were compared with manu-
ally created alignments, which demonstrated excellent performance of
the approach.
improving information availability for post-marketing
management of vaccines
Most of the presented work has been developed in the context of
the ADVANCE project, which has been launched in 2013 to bring
together the different steak-holders of post-marketing management
of vaccines.180 The thesis at hand offers a number of insights and
applications.
We observed that public social media is not very helpful for identify-
ing vaccine safety signals. Public social media about vaccines mostly
witnessed the perception of other internet content rather than that they
expressed private experience with vaccines. Spontaneous reporting
systems may be better suited for providing early cues to vaccine safety
issues,230 but they suffer from other drawbacks such as under-reporting
and unverified reports.63,64,231 Public social media messages, however,
proved valuable for monitoring the public sentiment about vaccines.
Furthermore, social media are a powerful tool in shaping public senti-
ment, as recent political campaigns in the UK and US suggested. The
next question to ask is whether social media can be harnessed to man-
age a public sentiment crisis about a vaccine by targeted dissemination
of available evidence about vaccines.232
The use of social media for vaccine safety surveillance or public
sentiment monitoring has several limitations. The analysis of social
media constitutes a bias towards relatively young people with internet
access.89 Our first study had an additional bias towards an English-
speaking communities due to the query keywords that were used to
retrieve relevant messages. And because social media platforms are
continually being re-engineered to improve the commercial service,
there is the concern as to whether studies conducted on data collected
from these platforms are reproducible.92
Automatic extraction of vaccine-related information from scientific
literature provides rapid access to available evidence. The accurate re-
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cognition of vaccine descriptions is fundamental to the extraction of any
relational information about vaccines. The RELigator model for extract-
ing chemically-induced diseases could be specialized in the extraction
of vaccine adverse events by narrowing its scope of causal agents from
chemicals to vaccines using the recognition of vaccine descriptions.
Automatic extraction of vaccine-related information from scientific liter-
ature is applicable in two settings. On the one hand, available evidence
about a vaccine can be compiled on request, for example to rapidly
assess a vaccine safety signal or to communicate evidence in order
to raise public confidence into a vaccination program. On the other
hand, automatic extraction could be used for creating and maintaining
a comprehensive inventory of established evidence about vaccines in
general. Partial and manually created attempts exist,35 but a complete
and up-to-date inventory would be useful for researchers for fast in-
formation access, or for health professionals and the public to inform
individual vaccination decisions. The transfer of the proposed methods
for information extraction from scientific literature to other free-text
resources of established vaccine evidence remains to be assessed (e.g.,
clinical trial reports or summary of product characteristics).
Several computer applications resulted from this thesis and can assist
the implementation of collaborative observational studies about vaccine
B/R by solving the representational heterogeneity of medical outcomes
and vaccines in EHR databases. The CodeMapper application has
been evaluated or used in a number of research projects and industry
(ADVANCE, European Medical Information Framework (EMIF),173
National Vaccine Program Office (NVPO),233 and Entresto®) since its
inception. It has, for example, been applied in the ADVANCE project for
the mapping of 45 outcomes. The automatic concept identification and
revision operations allowed a quick drafting and interactive exploration
of the code sets, without requiring extensive knowledge of the targeted
vocabularies. Feedback from medical experts and database custodians,
and harmonization between databases were crucial to identify missing
codes and concepts, and was collected in CodeMapper for subsequent
revision of the mappings. Together with the detailed history of all steps
that resulted in the mapping, CodeMapper facilitated an integrated
and transparent management of the overall mapping process.
In addition to knowledge of database codes, terminology mapping
requires clinical knowledge about the event, epidemiological know-
ledge including an understanding of the study goals, and knowledge
about the representation of medical events in the databases, which are
introduced during the manual revision in CodeMapper’s approach.
According to the experience in the ADVANCE project, terminology
mapping of the events can be performed most efficiently by smaller
teams where single members contribute expertise in several of these
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topics. Each team should be led by the principal investigator of the
study who should have expertise in extraction of events from health-
care databases, has the objective of the study in view, and takes final
decisions about the exclusion or inclusion of medical concepts based
on the input of the event team.234
CodeMapper has several limitations, most of them owing to the
basic design decision that the manual revision operates only on med-
ical concepts, and code sets are automatically generated based on the
assignments of codes to concepts in the Unified Medical Language
System (UMLS). This design decision was taken to ensure equivalence
between the code sets generated for different coding systems, assuming
consistent assignments in the UMLS. As a result, CodeMapper cannot
create extraction queries for databases that use custom coding systems
not included in the UMLS or free text to represent medical informa-
tion. And inconsistencies in the UMLS may crop up as inconsistencies
between the code sets generated by CodeMapper.185–188
CodeMapper’s approach could be developed further into two direc-
tions. First, mapping a medical outcome using CodeMapper starts with
an analysis of a textual case definition. Alternatively, a mapping could
likewise be built upon an existing code set that has been used before
to extract the outcome from a single database. CodeMapper’s engine
for identifying medical concepts also recognizes codes, which would
permit an experimental evaluation if the proposed workflow could be
improved by using an existing code set instead of a textual case defini-
tion as a starting point. Second, a discrepancy between medical case
definitions and EHRs impeded the creation of database extraction quer-
ies using CodeMapper’s approach in practice. Whereas the purpose
of medical case definitions is to establish a diagnosis based on signs
and symptoms under full availability of information (i.e., by examining
a patient), EHRs contain only information about a medical event that
is relevant for the purpose of the database (e.g., final diagnoses in
primary care databases, or medications in reimbursement databases).
Consequently, extraction queries have to take the specific purposes of
the databases into account. This could be realized by defining for each
medical event several operational case definitions that describe the
event with respect to the different database purposes. CodeMapper’s
approach can then be used to broaden the operational definitions to
code sets used in the EHR database of the same types. Gini et al., for
example, created separate mappings with CodeMapper to generated
different code sets for EHR databases of different types.235
The VaccO ontology provides the basis for recognizing, representing,
and reasoning about vaccine descriptions, and can be applied to the
extraction of vaccinations from EHR databases by means of three web
applications.114 The application ‘Analyse’ allows the user to enter a
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Figure 8.2: An XKCD comic hits the nail on the head once again (source:
https://xkcd.com)
vaccine description (e.g., a code descriptor) and presents the properties
in the description derived using the domain-specific knowledge from
the VaccO ontology. The application ‘Selector’ analyses all codes of
a user-provided vaccine coding system and allows for filtering the
vaccine codes by their derived properties. The application ‘Alignment’
lets the user upload two vaccine coding systems and generates an
alignment between them based on the code descriptors. This can be
used to create code mappings between the coding system used to define
a vaccine exposure in the study protocol and the coding systems used
to represent vaccinations in the EHR databases.
Methods for broadening event definitions or for unifying database
codes will remain useful to the conduction of collaborative observa-
tional studies as long as the representational heterogeneity between
databases persists. Different initiatives have been put forwards to elim-
inate the heterogeneity altogether by establishing a common data model
(CDM) that specifies the database layout and coding systems to which
databases have to conform to enable the extraction of medical outcomes
based on a single database query. Several standardization initiatives
exist, for example the OMOP common data model from the OHDSI
project for EHR databases, and the ISO IDMP standard for recording
medical products including vaccines.179,229 However, due to the ‘glacial
speed’ of changes in EHR databases, a potentially slow adaption can
temporarily result in an even more heterogeneous situation (figure 8.2).
Moreover, the migration of a database to a CDM still requires the map-
ping of custom, database-specific coding systems to the coding system
imposed by the CDM.
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types of representational heterogeneity and their res-
olution
This thesis tapped a number of resources for accessing vaccine-related
information: public social media messages for vaccine safety concerns
and public sentiment vaccines, scientific literature for established evid-
ence about vaccines, and EHR databases for vaccinations and outcomes.
We observed three types of representational heterogeneity.
First, representational heterogeneity in free text may be due to the
use of different languages and terminologies, of synonyms (e.g., ‘im-
munization’ or ‘vaccination’), and of syntactic term variation. Free text
was pervasive in this thesis and the primary content of social media
messages, case definitions, and scientific literature, and secondary con-
tent as descriptors in vaccine coding systems. Linguistic heterogeneity
was addressed in the step of recognition of relevant information. The
presented methods were mostly based on dictionaries, which aggreg-
ated various terms describing a concept. Dictionaries proved a simple
and reliable tool for the recognition of information. Their use in REL-
igator showed that the performance of dictionary-based approaches is
comparable to the performance of machine-learning approaches but
they require less or no training data. Dictionary-based approaches
can easily be adapted to multilingual input: To recognize countries in
social media messages we compiled a multilingual dictionary from the
Geonames database, which includes geographical terms in various lan-
guages and terminologies.106 And the dictionary of the VaccO ontology
was initially compiled from different resources of English terms and
subsequently translated to a number of European languages using an
automatic translation service.105 Comprehensive multilingual resources
are generally rare or unbalanced between languages (e.g., the UMLS),
but automatic translation services cover by now hundreds of languages
and achieve high performance.236,237
Second, medical information is represented in European EHR data-
base using different medical coding systems, which was addressed in
part III. Any collaborative observational study that covers databases
with different coding systems requires mappings between the coding
systems. For CodeMapper, we used existing mappings between the
coding systems to harmonize the different extraction queries for a med-
ical event. But the mappings between coding systems are not always
available and with VaccO we developed an method to automatically
create mappings between vaccine coding systems.
Third, corresponding information can be represented on different
taxonomic levels (e.g., products vs. pharmacological classes) and the de-
scription of equivalent information can be based on different properties
(e.g., defining a vaccine by pathogen as in ‘HPV vaccine’ or by disease
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as in ‘cervical cancer vaccine’). Such conceptual heterogeneity occurs
independently of the type of content (free text or code descriptors)
and its resolution requires automatic reasoning using domain-specific
knowledge. The best-performing method for the alignment of vaccine
codes represented vaccine descriptions in the VaccO ontology and
applied an ontology reasoner to resolve conceptual differences.
Automatic methods for resolving representational heterogeneity can
be based on an analysis of the task, the domain, or exemplary answers,
depending on the specific task and the availability of information
resources, and with consequences for the interpretability and sustain-
ability of the resulting models.54 An analysis of the task (including the
resource) underlies the creation of rule-based methods. For example,
we manually compiled dictionaries that captured how specific vaccines
and outcomes are described in social media. Task-based methods can
easily be created in an iterative process to solve small-scale problems,
but they are not well suited for large-scale tasks due to their inflexibility.
For example, the heuristics used to annotate vaccine descriptions based
on sentence co-occurrence between vaccines and properties turned out
as major error source in our model for vaccine-description recognition.
Automatic methods for vaccine semantics can be implemented based
on formalized domain-knowledge. The formalization of domain-specific
knowledge requires initially great manual effort, but such resource can
subsequently be used to solve different tasks in a domain. For ex-
ample, information from the UMLS was applied in all three steps of
vaccine semantics throughout this thesis: the recognition of concepts
was based on dictionaries compiled from the UMLS (chapters 4 to 7),
concepts were represented by UMLS concept unique identifiers (CUIs)
in RELigator and CodeMapper, and the reasoning underlying the se-
mantic operations in CodeMapper were based on the semantic relations
from the UMLS. The VaccO ontology was created for the alignment
of vaccine coding systems and applied to the recognition of vaccine
descriptions. Further examples of domain-specific knowledge in this
thesis were the Euretos knowledge graph for creating feature sets for
RELigator and the Geonames database for recognizing countries in
multilingual social media messages.
Finally, methods for vaccine semantics can be automatically derived
from a training material of exemplary answers to the task by super-
vised machine learning. Machine-learning methods are independent
from a manual analysis of the task or domain and capable of develop-
ing internal representations and generalizations for a large variety of
tasks.238 They offer high flexibility for automatic information extraction
and categorization. In the context of this thesis, training material were
only available for the classification of vaccine literature and the relation
extraction of chemical-induced diseases (from Pubmed and the Biocreat-
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ive V challenge, respectively). We compared different machine-learning
methods and feature sets for the classification of scientific articles, and
a CNN using word-embeddings performed best. The RELigator system
used a support vector machine to classify chemical-induced diseases.
However, the training of machine learning models requires sub-
stantial annotated, task-specific material, which are unavailable for
most information extraction tasks in the B/R monitoring of vaccines.
Additional experiments for chapter 4 showed that typically 50-60 art-
icles were required for one vaccine code to train a CNN model that
performed better than the ontology-based model. In the absence of
task-specific training material, formalized, domain-specific knowledge
is fundamental for implementing automatic methods for solving repres-
entational heterogeneity. Machine learning further results in black-box
models that make the analysis and understanding of specific behaviour
challenging. The behaviour of applications of domain-knowledge is
usually interpretable, which allows, for example, for tracking down the
reasons of incorrect behaviour to errors in the formalized domain know-
ledge in the application, where they can be corrected. The RF-VaccO
model and RELigator showed the value of combining domain-specific
knowledge with machine learning. Integrating deep learning models
(e.g., CNN) with domain-specific knowledge may be challenging, but
promises to further improve performance in classification tasks.238
The sustainability of automatic methods depends on their currency,
i.e., on keeping them up-to-date with respect to changes in the task
and the context. Most common changes in the context of vaccines come
from new vaccine developments (e.g., immunization targets and vaccine
strategies) and the authorization of new vaccine products. Bringing rule-
based and example-based methods up-to-date requires considerable
effort and specialized personnel: for rule-based methods, a programmer
has to update the program code with potentially growing complexity to
reflect the changes, and updating example-based methods requires the
manual creation of training material that reflects the changes, and the
retraining of the model.239 Resources of formalized domain-knowledge
can be created and updated in two ways. When created manually,
dedicated software is commonly used and can also be applied for
integrating changes (Protégé in the case of the VaccO ontology240).
When compiled from a broader resource by a computer program (from
EMA’s article 57 database in the case of the VaccO ontology241), the
creation process can be repeated when the underlying resource has
been updated. In either case, sustainability of automatic methods to
vaccine semantics requires comprehensive instructions how the relevant
data was created, to enable a consistent and timely update.

9
S U M M A RY
Post-marketing management and decision-making about vaccines builds
upon the timely detection of vaccine safety signals and changes in pub-
lic sentiment, established evidence about a vaccine, and the quantifica-
tion of benefits and risks and the verification of hypotheses about the
benefits and risks (B/R) of vaccines in observational studies. Prompt
and accurate access to such vaccine-related information is fundamental
to ensure the safety of vaccination programmes and to maintain public
confidence. Several resources provide relevant insights about vaccines
but the representation of information differs between and within re-
sources, which impedes information extraction. This thesis proposed
automatic methods to retrieve vaccine-related information from re-
sources in view of such representational heterogeneity.
Part I was motivated by the question if public social media messages
capture information that is relevant for the post-marketing management
of vaccines. Chapter 2 explored the use of social media messages
to monitor vaccine safety concerns by analysing English messages
mentioning an HPV vaccine and infertility, a supposed adverse event.
Publicly available data from the considered social media networks
were sparse and largely untrackable for the purpose of providing early
clues of safety concerns. Chapter 3 targeted the monitoring of public
sentiment towards a vaccine in a multinational debate by analysing
international, multilingual messages about a pentavalent vaccine, which
had previously been introduced in numberous lower and middle-
income countries. The messages that were analysed in both studies
possessed three salient properties: frequent references to other websites
(particularly news pages), few interactions between users (i.e., few
replies or reposts), and virtual absence of personal reports about the
vaccines. This may, however, come as little surprise given that only
public messages were analysed, whereas personal experiences may
rather be expressed in private messages, which were unavailable for
the purpose of the studies.
The debate as manifested in social media was portrayed by peaks of
messages following events in country-specific vaccination programmes.
The perception of events was local: users reacted largely to events in
their own country or adjacent countries, suggesting multiple, national
debates rather than a multinational debate. The messages did not dir-
ectly reflect the public’s sentiment about the vaccine issues or events,
because most messages by private persons were composed only by
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references to news pages that covered major events in the implementa-
tion of vaccination programmes. The messages, however, may reflect
the users’ sentiment indirectly exactly because the lack of additional,
personal content suggests that the authors generally concur with the
referenced content. The dominant concern in referred websites was
about the safety of the vaccine.
Part II proposed automatic methods underlying the extraction of
established evidence about vaccines from scientific literature. Chapter 4
focused on the recognition of vaccine descriptions and on the classi-
fication of research articles by vaccines. The proposed method for the
recognition of vaccine descriptions used the VaccO ontology of vaccine
descriptions to recognize vaccines and their properties, and a simple
heuristic to annotate vaccine descriptions based on the co-occurrence
of vaccines and properties within sentences. The method performed
reasonably well (F-score 0.69) in comparison to the inter-annotator
agreement of the manually created reference corpus of vaccine descrip-
tions (F-score 0.80). The error analysis revealed two possible ways for
improving the approach. First, the VaccO ontology should be expanded
with non-European vaccines, vaccines under development, and their
properties. Second, the rule-based heuristic to annotate descriptions
based on sentence co-occurrence was a major error source and should
take into account the textual context of recognized vaccines and prop-
erties. The reference corpus of vaccine descriptions that we developed
is the first of its kind and publicly available for training and testing of
future methods.
For the classification of vaccine articles, we compared dictionary-
based, ontology-based, statistical, and hybrid methods to assign vaccine
codes from the MeSH vocabulary by an analysis of the article title and
abstract. A simple dictionary of vaccine descriptions lacked the ne-
cessary flexibility in light of the large syntactic variation of vaccine
descriptions in scientific literature (F-score 0.45). The ontology-based
method derived a list of properties of the articles from the vacco onto-
logy and applied the alignment algorithm (chapter 7) for the assignment
of relevant MeSH vaccine codes. The algorithm, which proved suitable
for aligning descriptors between vaccine coding systems, had only
moderate performance for categorizing vaccine literature (F-score 0.60).
The better performance of a hybrid random forest model based on the
property list derived from VaccO appeared a more robust approach
for assigning vaccine headings (F-score 0.68). A CNN constituted the
best model for categorizing vaccine literature but required substantial
training material to train classifiers that perform well (F-score 0.76).
The performance of the CNN with respect to a single code correlated
strongly with the number of articles with that code in the training set.
The CNN performed better than the ontology-based method for almost
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all frequent vaccine codes but was outperformed by it for most infre-
quent codes. Vaccine codes, however, may necessarily be infrequent in
the training data for novel or less-studied vaccines. To further improve
performance, the neural network-based method and the ontology-based
methods could be combined dependening on the number of training
examples.
Chapter 5 covered the extraction of causal relations between chem-
icals and diseases rather than vaccines, but this work would support
equally well vaccine-related extractions. The extraction system, REL-
igator, was implemented by a support vector machine, using feature
sets based on a linguistic analysis of the article, information extracted
from the Euretos knowledge graph, and statistics about words in the
training set. RELigator achieved an F-score of 0.60, and each of the
features sets contributed to the final system performance.
Part III presented methods to retrieve vaccines and outcomes from
EHR databases that use different coding systems. In chapter 6, we
presented CodeMapper, a web application that assists in the mapping
of clinical case definitions into code sets from multiple coding systems,
which is often a bottleneck in the implementation of collaborative
observational studies. CodeMapper constitutes a single entry point
for all phases of creating database-specific code sets for a medical
outcome: the identification of relevant medical concepts from the case
definition, the manual revision of medical concepts, and the projection
to database-specific code sets. A number of semantic operations in
CodeMapper help in retrieving related medical concepts during the
manual revision. The overall mapping process is automatically recorded
and manual descriptions of the process are regularly requested, which
makes the mapping process traceable and the mappings more suitable
to subsequent studies. CodeMapper and its source code are publicly
available. We evaluated the effectiveness of CodeMapper’s approach by
simulating an informed usage. Creating a mapping without revising
the concepts was insufficient for reproducing the reference code sets,
indicating that the mapping process cannot be replaced by a simple
indexing step. However, the goal of CodeMapper is to support an
informed user in creating such mappings, and our evaluation showed
that CodeMapper’s semantic operations provided an effective and
efficient way (sensitivity 0.95 and precision 0.62).
Chapter 7 presented the VaccO ontology of vaccine descriptions,
and evaluated different automatic methods for the alignment of corres-
ponding vaccine codes between coding systems. The VaccO ontology
defines classes for vaccine products and vaccine properties, namely
immunization targets (including pathogens and diseases), immuniza-
tion strategies, administration routes, valences, and ingredients. VaccO
is agnostic of any specific vaccine coding systems: the basic class of
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vaccines does not subsume any codes but only classes that represent
pharmacological vaccine groups, common vaccine abbreviations (e.g.,
‘DTaP’) and vaccine products, which are defined by their relations to
other entities in the ontology. Each class includes a list of terms, which
can be used to identify references to the class in free text. The VaccO
ontology is publicly available.
The automatic methods for the alignment of corresponding vaccine
codes between different coding systems were based on multilingual
code descriptors, the only information about codes that is available in
all vaccine coding systems. Two baseline methods were defined based
on the overlap of words in the descriptors, and on the overlap of UMLS
concepts identified in the descriptors. The baseline methods were com-
pared with three methods built on the VaccO ontology, defined by the
overlap of VaccO classes recognized in the descriptors, the equivalence
between the logical expressions that represent the descriptors in VaccO,
and the overlap between properties inferred about the descriptors from
the ontology. The baseline methods lacked domain-specific knowledge
about vaccines and vaccine descriptions, and were generally outper-
formed by the methods built on the VaccO ontology. The method based
on the overlap of recognized VaccO classes outperformed the baseline
methods in the reference set with multilingual descriptors, due to
the multilingual dictionary in the VaccO ontology. The method based
on the equivalence of logical expressions correctly aligned codes of
equivalent vaccine groups described by different properties (e.g., ‘HPV
vaccine’ and ‘cervical cancer vaccine’). The method based on a flat
representation of inferred information additionally identified matching
codes across taxonomic levels, and demonstrated excellent performance
(F-scores 0.91 and 0.96 in two reference sets).
Accurate, automatic methods for extracting information from re-
sources with representational heterogeneity for the post-licensure vac-
cine management can be based on task-specific rules, formalized
domain-knowledge, or example solutions using supervised machine
learning. Formalized domain-knowledge provides the highest flex-
ibility for specific vaccine-related tasks, where training corpora are
unavailable.
S A M E N VAT T I N G
Vaccins worden door veel gezonde mensen gebruikt en zijn zeer ef-
fectief gebleken in het voorkomen van infectieziekten. Nadat vaccins
op de markt komen is het belangrijk dat de positieve effecten en bij-
werking goed worden gevolgd zodat het publiek vertrouwen houdt
in de programma’s. Hiervoor is snelle en goede toegang tot relevante
informatie van essentieel belang. Er zijn vele verschillende bronnen
met relevante informatie over vaccins, maar de representatie van de
informatie verschilt tussen en binnen deze bronnen, wat het extraheren
van informatie bemoeilijkt. Dit proefschrift beschrijft verschillende ge-
automatiseerde methoden om informatie over vaccins uit bronnen met
representationele heterogeniteit, te halen.
Deel I richt zich op publieke sociale media als informatie bron.
In hoofdstuk 2 onderzochten we of social media berichten gebruikt
konden worden om signalen op te pikken omtrent HPV-vaccin en on-
vruchtbaarheid, een veronderstelde bijwerking. Hoofdstuk 3 keek of
social media analyse een bijdrage zou kunnen hebben bij het monitoren
van de multinationale publieke opinie over het pentavalente vaccin.
De berichten die in deze studies werden geanalyseerd, hadden drie
opvallende eigenschappen: frequente verwijzingen naar andere websi-
tes (met name nieuwspagina’s), weinig interacties tussen gebruikers
(d.w.z. weinig antwoorden of reposts), en het vrijwel ontbreken van
persoonlijke rapporten over de vaccins. Het debat zoals dat zich in
de sociale media manifesteerde, werd gekarakteriseerd door pieken in
de berichten naar aanleiding van gebeurtenissen in landenspecifieke
vaccinatieprogramma’s. De perceptie van de gebeurtenissen was lo-
kaal: de gebruikers reageerden grotendeels op gebeurtenissen in hun
eigen land of aangrenzende landen, wat meerdere nationale debatten
in plaats van een multinationaal debat suggereert. De berichten gaven
niet direct het sentiment van het publiek over de vaccinatiekwesties
of -gebeurtenissen weer, omdat de meeste berichten van particulie-
ren alleen waren samengesteld uit verwijzingen naar nieuwspagina’s
over belangrijke gebeurtenissen bij de uitvoering van vaccinatiepro-
gramma’s. De berichten kunnen echter indirect het sentiment van de
gebruikers weerspiegelen, juist omdat het gebrek aan aanvullende,
persoonlijke inhoud suggereert dat de auteurs het in het algemeen eens
zijn met de inhoud waarnaar verwezen wordt. De belangrijkste zorg
op de websites waarnaar wordt verwezen, was de veiligheid van het
vaccin.
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Deel II richtte zich op de de wetenschappelijke literatuur als bron
voor informatie. Hoofdstuk 4 richtte zich op de herkenning van vaccin-
beschrijvingen en de classificatie van wetenschappelijke artikelen. Om
vaccins te herkennen werd de VaccO-ontologie gebruikt. De methode
presteerde redelijk goed (F-score 0,69) in vergelijking met de interan-
notatorovereenkomst van het handmatig gemaakte referentiecorpus
van vaccinbeschrijvingen (F-score 0,80). De foutanalyse bracht twee
mogelijke manieren aan het licht om de aanpak te verbeteren. Ten
eerste moet de VaccO-ontologie worden uitgebreid met niet-Europese
vaccins en vaccins in ontwikkeling, samen met hun eigenschappen. Ten
tweede was de gebruikte heuristiek een belangrijke bron van fouten en
moet in plaats daarvan rekening worden gehouden met de tekstuele
context van herkende vaccins en eigenschappen. Het referentiecorpus
van vaccinbeschrijvingen dat werd ontwikkeld, is het eerste in zijn
soort en publiek beschikbaar voor training en testen van toekomstige
methoden.
Voor de classificatie van vaccinartikelen vergeleken we woordenboek-
gebaseerde, ontologie-gebaseerde, statistische en hybride methoden
om vaccincodes toe te wijzen uit de MeSH-vocabulaire. Een eenvoudig
woordenboek van vaccinbeschrijvingen miste de nodige flexibiliteit in
het licht van de grote syntactische variatie van vaccinbeschrijvingen in
de wetenschappelijke literatuur (F-score 0,45). De ontologie-gebaseerde
methode berekende de vlakke representatie van informatie uit de
VaccO-ontologie voor de artikelen en paste het aligneringsalgoritme
(hoofdstuk 7) toe voor de toewijzing van relevante MeSH-vaccincodes.
Het algoritme, dat geschikt bleek voor het aligneren van descriptoren
uit verschillende vaccincoderingssystemen, had een matige prestatie
voor het categoriseren van vaccinliteratuur (F-score 0,60). De betere
prestaties van een hybride random forest model gebaseerd op de vlakke
representatie van VaccO-informatie bleek een robuustere aanpak voor
het toewijzen van vaccinkoppen (F-score 0,68). Een convolutioneel neu-
raal netwerk (CNN) vormde het beste model voor het categoriseren
van vaccinliteratuur, maar vereiste een substantiële hoeveelheid trai-
ningsmateriaal om goed presterende classificatoren te trainen (F-score
0,76). De prestaties van de CNN voor een specifieke code correleer-
den sterk met het aantal artikelen met die code in de trainingsset.
De CNN presteerde beter dan de ontologie-gebaseerde methode voor
bijna alle frequent voorkomende vaccincodes, maar presteerde minder
goed voor de meeste weinig voorkomende codes van nieuwe of minder
bestudeerde vaccins. De neurale netwerkgebaseerde methode en de
ontologiegebaseerde methoden zouden kunnen worden gecombineerd,
afhankelijk van het aantal beschikbare trainingsvoorbeelden, om de
prestaties verder te verbeteren.
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Hoofdstuk 5 had betrekking op de extractie van causale verbanden
tussen chemische stoffen en ziekten, maar dit werk zou evengoed vac-
cingerelateerde extracties kunnen ondersteunen. Het extractiesysteem,
RELigator, werd geïmplementeerd als een support vector machine, met
featuresets gebaseerd op een taalkundige analyse van het artikel, in-
formatie uit de Euretos-kennisgraaf en statistieken over woorden in de
trainingsset. RELigator behaalde een F-score van 0,60 en elk van de
featuresets droeg bij aan de uiteindelijke systeemprestatie.
Deel III presenteerde methoden om vaccins en uitkomsten te halen
uit internationale elektronische zorg databases- die gebruik maken
van verschillende coderingssystemen. In hoofdstuk 6 presenteerden
we een webapplicatie – CodeMapper – die helpt bij het vertalen van
klinische case definities naar codesets van verschillende coderingssyste-
men, wat vaak een knelpunt is bij de implementatie van collaboratieve
observationele studies. CodeMapper vormt één enkel toegangspunt
voor alle fasen in het creëren van database-specifieke codesets voor
een medische uitkomst: de identificatie van relevante medische con-
cepten in de casusdefinitie, de handmatige herziening van medische
concepten, en de projectie naar database-specifieke codesets. Verschil-
lende semantische operaties in CodeMapper helpen bij het vinden van
gerelateerde medische concepten tijdens de handmatige revisie. Het
hele mappingproces wordt automatisch geregistreerd en er worden
regelmatig manuele beschrijvingen van het proces gevraagd, waardoor
het mappingproces traceerbaar is en de mappings beter geschikt zijn
voor latere studies. CodeMapper en zijn broncode zijn publiek beschik-
baar. We hebben de effectiviteit van CodeMapper geëvalueerd door het
simuleren van een geïnformeerd gebruik bij de mapping van een aantal
casusdefinities. Het maken van een mapping zonder revisie van de
concepten was onvoldoende om de referentiecodesets te reproduceren,
wat aangeeft dat het mapping proces niet kan worden vervangen door
een eenvoudige indexeringsstap. Het doel van CodeMapper is echter
om een geïnformeerde gebruiker te ondersteunen bij het maken van
dergelijke mappings en uit onze evaluatie bleek dat de semantische
operaties van CodeMapper daarvoor een effectieve en efficiënte manier
zijn (sensitiviteit 0,95 en precisie 0,62).
Hoofdstuk 7 presenteerde VaccO, een applicatie-ontologie voor vac-
cinbeschrijvingen, en evalueerde verschillende geautomatiseerde me-
thoden voor de alignering van overeenkomstige vaccincodes in ver-
schillende coderingssystemen. De VaccO-ontologie definieert klassen
voor vaccinproducten en voor vaccineigenschappen, namelijk immu-
nisatiedoelen (pathogenen en ziekten), immunisatiestrategieën, toe-
dieningsroutes, valenties en ingrediënten. VaccO is agnostisch voor
specifieke vaccincoderingssystemen: de basisklasse van vaccins omvat
geen codes, maar alleen klassen die farmacologische vaccingroepen,
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algemene vaccinafkortingen (bv. ‘DTaP’) en vaccinproducten vertegen-
woordigen, en die worden gedefinieerd door hun relaties met andere
entiteiten in de ontologie. Elke klasse bevat een lijst van descriptoren,
die gebruikt kunnen worden om verwijzingen naar de klasse in vrije
tekst te identificeren. De VaccO-ontologie is openbaar.
De geautomatiseerde methoden voor de alignering van overeenkom-
stige vaccincodes tussen verschillende coderingssystemen waren geba-
seerd op meertalige codebeschrijvingen, de enige informatie over codes
die algemeen beschikbaar is in vaccincodeersystemen. Twee basismetho-
den werden gedefinieerd: woordoverlap in de descriptoren en overlap
van UMLS-concepten in de descriptoren. De basismethoden werden ver-
geleken met drie methoden gebaseerd op de VaccO-ontologie: overlap
van de VaccO-klassen die in de descriptoren worden herkend, equiva-
lentie tussen de logische uitdrukkingen die de descriptoren in VaccO
vertegenwoordigen, en overlap tussen de vlakke representaties van de
informatie die werd afgeleid over de descriptoren uit de ontologie. De
basismethoden ontbrak het aan domeinspecifieke kennis over vaccins
en vaccinbeschrijvingen, en werden in het algemeen overtroffen door
de methoden gebaseerd op de VaccO-ontologie. De methode gebaseerd
op de overlap van herkende VaccO-klassen presteerde beter dan de ba-
sismethoden in de referentieset met meertalige descriptoren, als gevolg
van het meertalige woordenboek in de VaccO-ontologie. De methode
gebaseerd op equivalentie van logische uitdrukkingen, aligneerde de co-
des van corresponderende vaccingroepen die werden beschreven door
verschillende eigenschappen (bv. ‘HPV vaccin’ en ‘cervicaal kankervac-
cin’). De methode gebaseerd op een vlakke representatie van afgeleide
informatie identificeerde ook overeenkomstige codes op verschillende
taxonomische niveaus, en gaf uitstekende prestaties (F-scores 0,91 en
0,96 in twee referentiesets).
Nauwkeurige, geautomatiseerde methoden voor het extraheren van
informatie uit bronnen met representatieve heterogeniteit voor het
post-licentiebeheer van vaccins, kunnen worden gebaseerd op taakspe-
cifieke regels, geformaliseerde domeinkennis of voorbeeldoplossingen
in combinatie met machinaal leren. Geformaliseerde domeinkennis
biedt de hoogste flexibiliteit voor specifieke vaccingerelateerde taken,
waar trainingscorpora niet beschikbaar zijn.
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